Go to the Table of Contents

100510
Table 1.47A – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Numbers in Thousands, 2008 and 2009
Demographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 16,555 16,599 536 508 268 167
GENDER            
Male 10,938 11,572 447 389 229 112
Female 5,618 5,027 89 119 39 55
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 15,048 15,299 503 401 247 122
White 13,531 14,189 424 349 204 101
Black or African American 799 577 11 * 11 *
American Indian or Alaska Native 71 69 2 2 * 0
Native Hawaiian or Other Pacific Islander * * * * * *
Asian 236 207 60 25 25 11
Two or More Races 394 246 6 24 6 9
Hispanic or Latino 1,508 1,300 33 107 21 46
EDUCATION            
< High School 1,734 1,814 29 54 19 8
High School Graduate 4,180 3,949 181 75 30 44
Some College 4,840 4,620 142 183 94 43
College Graduate 5,801 6,216 185 196 125 73
CURRENT EMPLOYMENT            
Full-Time 11,439 10,973 345 273 210 120
Part-Time 1,939 1,995 103 102 12 6
Unemployed 734b 1,226 50 60 21 17
Other1 2,444 2,405 38 74 25 23
100510
Table 1.47B – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Percentages, 2008 and 2009
Demographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 8.6 8.6 0.3 0.3 0.1 0.1
GENDER            
Male 11.9 12.5 0.5 0.4 0.2 0.1
Female 5.6 5.0 0.1 0.1 0.0 0.1
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 9.0 9.1 0.3 0.2 0.1 0.1
White 10.1 10.5 0.3 0.3 0.2 0.1
Black or African American 3.8 2.7 0.1 * 0.1 *
American Indian or Alaska Native 9.1 8.0 0.3 0.3 * 0.1
Native Hawaiian or Other Pacific Islander * * * * * *
Asian 2.8 2.4 0.7 0.3 0.3 0.1
Two or More Races 18.8 12.3 0.3 1.2 0.3 0.5
Hispanic or Latino 6.1 5.2 0.1 0.4 0.1 0.2
EDUCATION            
< High School 5.9 6.3 0.1 0.2 0.1 0.0
High School Graduate 7.1 6.8 0.3 0.1 0.1 0.1
Some College 10.4 9.9 0.3 0.4 0.2 0.1
College Graduate 10.0 10.3 0.3 0.3 0.2 0.1
CURRENT EMPLOYMENT            
Full-Time 10.7 10.7 0.3 0.3 0.2 0.1
Part-Time 8.9 8.9 0.5 0.5 0.1 0.0
Unemployed 12.4 12.0 0.8 0.6 0.4 0.2
Other1 4.3 4.1 0.1 0.1 0.0 0.0
100510
Table 1.48A – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Numbers in Thousands, 2008 and 2009
Demographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 19,967 20,180 1,069 1,134 372 315
GENDER            
Male 12,957 13,759 799 793 301 216
Female 7,010 6,421 270 341 71 99
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 17,956 18,295 959 892 327 232
White 16,166 16,887 831 789 274 198
Black or African American 945 726 31 19 13 9
American Indian or Alaska Native 89 112 5 7 0 0
Native Hawaiian or Other Pacific Islander 24 20 * 3 * 1
Asian 296 254 74 40 30 13
Two or More Races 436 296 14 33 6 9
Hispanic or Latino 2,011 1,886 110a 242 45 84
EDUCATION            
< High School 2,354 2,526 111 192 31 43
High School Graduate 5,335 5,215 384 288 78 93
Some College 6,006 5,759 350 407 127 100
College Graduate 6,271 6,681 224 248 135 79
CURRENT EMPLOYMENT            
Full-Time 13,109 12,448 542 446 250 159
Part-Time 2,823 2,916 278 269 51 62
Unemployed 1,062b 1,790 123 203 39 47
Other1 2,973 3,026 126a 217 32 47
100510
Table 1.48B – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, 2008 and 2009
Demographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 8.9 8.9 0.5 0.5 0.2 0.1
GENDER            
Male 11.9 12.5 0.7 0.7 0.3 0.2
Female 6.0 5.5 0.2 0.3 0.1 0.1
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 9.2 9.3 0.5 0.5 0.2 0.1
White 10.4 10.9 0.5 0.5 0.2 0.1
Black or African American 3.7 2.8 0.1 0.1 0.1 0.0
American Indian or Alaska Native 9.3 10.3 0.6 0.7 0.0 0.0
Native Hawaiian or Other Pacific Islander 3.0 2.7 * 0.4 * 0.1
Asian 3.0 2.5 0.8 0.4 0.3 0.1
Two or More Races 17.4 12.2 0.6 1.4 0.3 0.4
Hispanic or Latino 6.6 6.1 0.4a 0.8 0.1 0.3
EDUCATION            
< High School 6.7 7.3 0.3 0.6 0.1 0.1
High School Graduate 7.6 7.4 0.5 0.4 0.1 0.1
Some College 10.5 10.0 0.6 0.7 0.2 0.2
College Graduate 10.0 10.3 0.4 0.4 0.2 0.1
CURRENT EMPLOYMENT            
Full-Time 10.7 10.8 0.4 0.4 0.2 0.1
Part-Time 9.3 9.2 0.9 0.8 0.2 0.2
Unemployed 11.8 12.1 1.4 1.4 0.4 0.3
Other1 4.7 4.6 0.2a 0.3 0.1 0.1
100510
Table 1.49A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Demographic Characteristics: Numbers in Thousands, 2008 and 2009
Demographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 51,970 51,771 15,166 16,006 6,224a 6,953
AGE            
12-17 2,772 2,796 1,913 1,885 710 772
18-25 9,626 9,819 4,868 5,027 1,943 2,119
26 or Older 39,572 39,156 8,385 9,093 3,571 4,062
GENDER            
Male 27,179 26,979 7,673a 8,445 3,096b 3,840
Female 24,791 24,792 7,493 7,561 3,128 3,114
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 46,474 46,010 13,430 13,823 5,597 6,107
White 40,053 40,401 11,452 11,880 4,821 5,119
Black or African American 4,103a 3,519 1,276 1,216 539 599
American Indian or Alaska Native * 399 78 130 33 76
Native Hawaiian or Other Pacific Islander * * * * 15 *
Asian 1,015 816 323 302 108 155
Two or More Races 803 759 209 226 81 100
Hispanic or Latino 5,496 5,760 1,736a 2,183 627 847
100510
Table 1.49B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Demographic Characteristics: Percentages, 2008 and 2009
Demographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 20.8 20.6 6.1 6.4 2.5a 2.8
AGE            
12-17 11.1 11.4 7.7 7.7 2.9 3.1
18-25 29.2 29.2 14.8 15.0 5.9 6.3
26 or Older 20.6 20.2 4.4 4.7 1.9 2.1
GENDER            
Male 22.4 22.1 6.3 6.9 2.6b 3.1
Female 19.3 19.1 5.8 5.8 2.4 2.4
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 21.6 21.3 6.3 6.4 2.6 2.8
White 23.6 23.8 6.8 7.0 2.8 3.0
Black or African American 13.9a 11.7 4.3 4.0 1.8 2.0
American Indian or Alaska Native * 32.6 7.2 10.6 3.0 6.2
Native Hawaiian or Other Pacific Islander * * * * 1.7 *
Asian 9.4 7.4 3.0 2.7 1.0 1.4
Two or More Races 26.6 25.7 6.9 7.6 2.7 3.4
Hispanic or Latino 15.7 16.0 5.0a 6.1 1.8 2.4
100510
Table 1.50A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Demographic Characteristics: Numbers in Thousands, 2008 and 2009
Demographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 2,772 2,796 1,913 1,885 710 772
GENDER            
Male 1,255 1,345 863 876 312 352
Female 1,517 1,450 1,050 1,009 398 420
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 2,305 2,218 1,595 1,515 605 615
White 1,809a 1,639 1,270 1,158 490 446
Black or African American 312a 405 201 260 79a 129
American Indian or Alaska Native 22 22 15 14 5 4
Native Hawaiian or Other Pacific Islander * * * * * *
Asian 80 79 47 45 7 19
Two or More Races 67 59 51 32 21 14
Hispanic or Latino 466a 578 318 370 106a 157
GENDER/RACE/HISPANIC ORIGIN            
Male, White, Not Hispanic 809 779 564 543 223 209
Female, White, Not Hispanic 1,000a 860 706 615 267 237
Male, Black, Not Hispanic 165 205 101 126 32 56
Female, Black, Not Hispanic 147 201 100 133 47 73
Male, Hispanic 217 282 153 174 41a 74
Female, Hispanic 249 296 165 196 65 83
100510
Table 1.50B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Demographic Characteristics: Percentages, 2008 and 2009
Demographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 11.1 11.4 7.7 7.7 2.9 3.1
GENDER            
Male 9.9 10.7 6.8 7.0 2.5 2.8
Female 12.4 12.0 8.6 8.4 3.3 3.5
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 11.4 11.2 7.9 7.6 3.0 3.1
White 12.3 11.4 8.6 8.1 3.3 3.1
Black or African American 8.3b 10.9 5.3a 7.0 2.1b 3.5
American Indian or Alaska Native 16.3 16.8 11.3 11.1 4.0 3.0
Native Hawaiian or Other Pacific Islander * * * * * *
Asian 8.3 8.0 4.8 4.5 0.7 1.9
Two or More Races 13.3 11.2 10.2 6.1 4.2 2.6
Hispanic or Latino 9.9a 12.0 6.7 7.7 2.2a 3.3
GENDER/RACE/HISPANIC ORIGIN            
Male, White, Not Hispanic 10.8 10.6 7.5 7.4 3.0 2.8
Female, White, Not Hispanic 14.0a 12.3 9.9 8.8 3.7 3.4
Male, Black, Not Hispanic 8.7 11.0 5.3 6.8 1.7 3.0
Female, Black, Not Hispanic 7.8a 10.9 5.3 7.2 2.5 3.9
Male, Hispanic 9.0 11.4 6.4 7.1 1.7a 3.0
Female, Hispanic 10.8 12.6 7.1 8.4 2.8 3.5
100510
Table 1.51A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Demographic Characteristics: Numbers in Thousands, 2008 and 2009
Demographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 9,626 9,819 4,868 5,027 1,943 2,119
GENDER            
Male 5,110 5,205 2,623 2,787 1,038a 1,209
Female 4,516 4,614 2,244 2,240 905 910
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 8,272 8,402 4,253 4,331 1,737 1,807
White 7,027 7,237 3,592 3,752 1,463 1,567
Black or African American 753 736 413 361 183 148
American Indian or Alaska Native 64 85 30 47 10 30
Native Hawaiian or Other Pacific Islander * * * * 4 *
Asian 249a 170 117 93 46 33
Two or More Races 147 146 76 62 32 23
Hispanic or Latino 1,354 1,417 614 696 206a 312
EDUCATION            
< High School 1,786 1,924 943 994 401 480
High School Graduate 3,236 3,424 1,687 1,776 723 738
Some College 3,253 3,176 1,675 1,660 613 675
College Graduate 1,351 1,295 562 597 206 226
CURRENT EMPLOYMENT            
Full-Time 4,763b 3,774 2,255b 1,793 917a 764
Part-Time 2,274b 2,598 1,162b 1,409 445b 611
Unemployed 1,002b 1,486 553b 812 215b 345
Other1 1,587b 1,960 898 1,013 366 400
100510
Table 1.51B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Demographic Characteristics: Percentages, 2008 and 2009
Demographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 29.2 29.2 14.8 15.0 5.9 6.3
GENDER            
Male 30.8 30.8 15.8 16.5 6.3 7.2
Female 27.6 27.6 13.7 13.4 5.5 5.5
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 30.5 30.6 15.7 15.8 6.4 6.6
White 34.6 35.5 17.7 18.4 7.2 7.7
Black or African American 16.2 15.3 8.9 7.5 3.9 3.1
American Indian or Alaska Native 37.0 36.7 17.2 20.3 5.9 12.9
Native Hawaiian or Other Pacific Islander * * * * 3.3 *
Asian 16.7a 11.2 7.8 6.1 3.0 2.1
Two or More Races 35.8 34.1 18.4 14.5 7.7 5.4
Hispanic or Latino 23.4 23.1 10.6 11.4 3.6a 5.1
EDUCATION            
< High School 30.3 31.6 16.0 16.3 6.8 7.9
High School Graduate 27.9 29.2 14.5 15.1 6.2 6.3
Some College 30.0 28.7 15.4 15.0 5.6 6.1
College Graduate 29.5 27.5 12.3 12.7 4.5 4.8
CURRENT EMPLOYMENT            
Full-Time 31.8 30.5 15.1 14.5 6.1 6.2
Part-Time 26.6 27.7 13.6 15.0 5.2a 6.5
Unemployed 32.8 32.6 18.1 17.8 7.0 7.6
Other1 25.0 26.9 14.1 13.9 5.8 5.5
100510
Table 1.52A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Numbers in Thousands, 2008 and 2009
Demographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 39,572 39,156 8,385 9,093 3,571 4,062
GENDER            
Male 20,813 20,429 4,186 4,782 1,746a 2,278
Female 18,758 18,727 4,199 4,311 1,825 1,784
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 35,896 35,390 7,582 7,977 3,255 3,685
White 31,216 31,526 6,590 6,969 2,868 3,106
Black or African American 3,039a 2,378 661 596 277 323
American Indian or Alaska Native * * 33 * 17 *
Native Hawaiian or Other Pacific Islander * * * * * *
Asian 686 567 159 164 56 103
Two or More Races 589 554 82 131 28 63
Hispanic or Latino 3,676 3,766 803 1,116 315 377
EDUCATION            
< High School 4,868 4,947 1,223 1,538 540a 827
High School Graduate 11,871 11,153 2,589 2,619 1,072 1,190
Some College 11,162 10,948 2,489 2,350 1,248 1,103
College Graduate 11,671 12,108 2,084a 2,587 711 942
CURRENT EMPLOYMENT            
Full-Time 25,761a 23,654 5,303 5,114 2,079 2,047
Part-Time 5,138 4,896 969 1,204 364 487
Unemployed 1,650b 3,025 585a 832 264 421
Other1 7,023 7,580 1,528a 1,944 864 1,107
100510
Table 1.52B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Percentages, 2008 and 2009
Demographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 20.6 20.2 4.4 4.7 1.9 2.1
GENDER            
Male 22.6 22.0 4.6 5.2 1.9a 2.5
Female 18.8 18.6 4.2 4.3 1.8 1.8
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 21.4 21.0 4.5 4.7 1.9 2.2
White 23.2 23.3 4.9 5.2 2.1 2.3
Black or African American 14.4b 11.0 3.1 2.8 1.3 1.5
American Indian or Alaska Native * * 4.2 * 2.2 *
Native Hawaiian or Other Pacific Islander * * * * * *
Asian 8.2 6.6 1.9 1.9 0.7 1.2
Two or More Races 28.0 27.7 3.9 6.6 1.3 3.2
Hispanic or Latino 15.0 15.1 3.3 4.5 1.3 1.5
EDUCATION            
< High School 16.7 17.3 4.2 5.4 1.9a 2.9
High School Graduate 20.3 19.1 4.4 4.5 1.8 2.0
Some College 24.1 23.5 5.4 5.0 2.7 2.4
College Graduate 20.2 20.2 3.6 4.3 1.2 1.6
CURRENT EMPLOYMENT            
Full-Time 24.0 23.1 4.9 5.0 1.9 2.0
Part-Time 23.7 21.8 4.5 5.4 1.7 2.2
Unemployed 27.8 29.7 9.9 8.2 4.5 4.1
Other1 12.3 12.9 2.7 3.3 1.5 1.9
100510
Table 1.53A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Numbers in Thousands, 2008 and 2009
Demographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 49,198 48,975 13,253 14,120 5,514a 6,182
GENDER            
Male 25,924 25,634 6,810a 7,569 2,784b 3,488
Female 23,274 23,341 6,443 6,552 2,730 2,694
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 44,168 43,793 11,835 12,308 4,992 5,492
White 38,244 38,763 10,183 10,722 4,331 4,673
Black or African American 3,791a 3,114 1,074 956 459 471
American Indian or Alaska Native * 377 62 116 27 72
Native Hawaiian or Other Pacific Islander * * * * 13 *
Asian 935 737 276 257 101 136
Two or More Races 736 700 158 194 60 87
Hispanic or Latino 5,030 5,182 1,418a 1,812 522 690
EDUCATION            
< High School 6,654 6,871 2,166 2,532 942b 1,307
High School Graduate 15,107 14,577 4,276 4,395 1,795 1,928
Some College 14,415 14,124 4,164 4,009 1,861 1,779
College Graduate 13,022 13,403 2,646a 3,184 917 1,168
CURRENT EMPLOYMENT            
Full-Time 30,524b 27,428 7,558 6,907 2,997 2,811
Part-Time 7,412 7,494 2,131a 2,612 809a 1,098
Unemployed 2,652b 4,512 1,138b 1,644 479b 766
Other1 8,610 9,540 2,426a 2,957 1,229 1,507
100510
Table 1.53B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, 2008 and 2009
Demographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 21.9 21.6 5.9 6.2 2.5 2.7
GENDER            
Male 23.9 23.4 6.3 6.9 2.6b 3.2
Female 20.0 19.9 5.5 5.6 2.3 2.3
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 22.7 22.3 6.1 6.3 2.6 2.8
White 24.7 24.9 6.6 6.9 2.8 3.0
Black or African American 14.7b 11.8 4.2 3.6 1.8 1.8
American Indian or Alaska Native * 34.4 6.6 10.6 2.9 6.6
Native Hawaiian or Other Pacific Islander * * * * 1.7 *
Asian 9.5 7.3 2.8 2.6 1.0 1.4
Two or More Races 29.3 28.8 6.3 8.0 2.4 3.6
Hispanic or Latino 16.6 16.6 4.7 5.8 1.7 2.2
EDUCATION            
< High School 19.0 19.8 6.2 7.3 2.7b 3.8
High School Graduate 21.5 20.8 6.1 6.3 2.6 2.8
Some College 25.2 24.5 7.3 6.9 3.3 3.1
College Graduate 20.8 20.7 4.2 4.9 1.5 1.8
CURRENT EMPLOYMENT            
Full-Time 25.0 23.9 6.2 6.0 2.5 2.4
Part-Time 24.5 23.6 7.0 8.2 2.7a 3.5
Unemployed 29.5 30.6 12.7 11.1 5.3 5.2
Other1 13.6 14.5 3.8 4.5 1.9 2.3
100510
Table 1.54A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Demographic Characteristics: Numbers in Thousands, 2008 and 2009
Demographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 34,861 35,046 11,885 12,405 4,747 5,257
AGE            
12-17 2,346 2,378 1,608 1,616 567 653
18-25 8,042 8,156 3,941 4,000 1,502 1,600
26 or Older 24,473 24,513 6,336 6,789 2,678 3,004
GENDER            
Male 18,913 19,365 6,373 6,865 2,469a 2,976
Female 15,948 15,682 5,513 5,539 2,278 2,281
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 30,915 31,047 10,506 10,717 4,249 4,621
White 26,455 26,780 8,788 9,037 3,556 3,778
Black or African American 2,999 2,714 1,141 1,064 483 483
American Indian or Alaska Native 144a 327 62 125 27 74
Native Hawaiian or Other Pacific Islander 137 * * * 12 *
Asian 698 596 273 250 99 148
Two or More Races 482 538 155 178 73 83
Hispanic or Latino 3,946 4,000 1,379 1,688 497 636
100510
Table 1.54B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Demographic Characteristics: Percentages, 2008 and 2009
Demographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 14.0 13.9 4.8 4.9 1.9 2.1
AGE            
12-17 9.4 9.7 6.5 6.6 2.3a 2.7
18-25 24.4 24.3 12.0 11.9 4.6 4.8
26 or Older 12.7 12.7 3.3 3.5 1.4 1.6
GENDER            
Male 15.6 15.8 5.3 5.6 2.0a 2.4
Female 12.4 12.1 4.3 4.3 1.8 1.8
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 14.4 14.4 4.9 5.0 2.0 2.1
White 15.6 15.8 5.2 5.3 2.1 2.2
Black or African American 10.1 9.0 3.9 3.5 1.6 1.6
American Indian or Alaska Native 13.3a 26.7 5.8 10.2 2.5 6.0
Native Hawaiian or Other Pacific Islander 15.2 * * * 1.3 *
Asian 6.5 5.4 2.5 2.3 0.9 1.3
Two or More Races 16.0 18.2 5.1 6.0 2.4 2.8
Hispanic or Latino 11.3 11.1 3.9 4.7 1.4 1.8
100510
Table 1.55A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Demographic Characteristics: Numbers in Thousands, 2008 and 2009
Demographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 2,346 2,378 1,608 1,616 567 653
GENDER            
Male 1,064 1,169 728 751 250 300
Female 1,282 1,208 880 866 317 353
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 1,952 1,874 1,343 1,283 482 513
White 1,543a 1,374 1,067 967 385 368
Black or African American 268a 351 173 227 64a 107
American Indian or Alaska Native 17 19 14 12 5 3
Native Hawaiian or Other Pacific Islander * * * * * *
Asian 51 68 35 41 7 18
Two or More Races 61 53 43 29 19 13
Hispanic or Latino 394a 503 266 334 85a 140
GENDER/RACE/HISPANIC ORIGIN            
Male, White, Not Hispanic 684 669 482 453 179 177
Female, White, Not Hispanic 858b 705 585 514 206 191
Male, Black, Not Hispanic 141 179 82 110 26 46
Female, Black, Not Hispanic 127 173 90 117 38 61
Male, Hispanic 186 251 124 157 30a 66
Female, Hispanic 207 252 142 177 54 74
100510
Table 1.55B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Demographic Characteristics: Percentages, 2008 and 2009
Demographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 9.4 9.7 6.5 6.6 2.3a 2.7
GENDER            
Male 8.4 9.3 5.7 6.0 2.0 2.4
Female 10.5 10.0 7.2 7.2 2.6 2.9
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 9.7 9.5 6.7 6.5 2.4 2.6
White 10.5a 9.6 7.3 6.7 2.6 2.6
Black or African American 7.1a 9.5 4.6a 6.1 1.7a 2.9
American Indian or Alaska Native 12.8 14.3 10.4 9.5 4.0 2.7
Native Hawaiian or Other Pacific Islander * * * * * *
Asian 5.3 6.9 3.7 4.1 0.7 1.9
Two or More Races 12.1 10.1 8.5 5.6 3.8 2.4
Hispanic or Latino 8.3a 10.5 5.6 6.9 1.8a 2.9
GENDER/RACE/HISPANIC ORIGIN            
Male, White, Not Hispanic 9.1 9.1 6.4 6.2 2.4 2.4
Female, White, Not Hispanic 12.0b 10.1 8.2 7.3 2.9 2.7
Male, Black, Not Hispanic 7.4 9.6 4.3 5.9 1.4 2.5
Female, Black, Not Hispanic 6.8a 9.4 4.8 6.3 2.0 3.3
Male, Hispanic 7.7 10.2 5.1 6.4 1.3a 2.7
Female, Hispanic 9.0 10.7 6.1 7.5 2.4 3.2
100510
Table 1.56A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Demographic Characteristics: Numbers in Thousands, 2008 and 2009
Demographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 8,042 8,156 3,941 4,000 1,502 1,600
GENDER            
Male 4,397 4,444 2,173 2,275 833 928
Female 3,645 3,712 1,768 1,726 669 672
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 7,015 7,052 3,477 3,457 1,345 1,369
White 5,972 6,071 2,916 2,981 1,102 1,177
Black or African American 660 647 362 305 165 115
American Indian or Alaska Native 44a 77 21a 45 10 28
Native Hawaiian or Other Pacific Islander * * * * * *
Asian 190a 123 97 69 36 28
Two or More Races 119 117 57 47 29 16
Hispanic or Latino 1,026 1,104 464 543 156a 231
EDUCATION            
< High School 1,557 1,623 804 820 339 385
High School Graduate 2,762 2,924 1,421 1,469 599 603
Some College 2,714 2,632 1,326 1,302 447 485
College Graduate 1,007 977 390 409 117 127
CURRENT EMPLOYMENT            
Full-Time 3,951b 3,140 1,853b 1,445 744a 595
Part-Time 1,874b 2,186 912b 1,117 325b 439
Unemployed 851b 1,251 444b 655 170b 274
Other1 1,365a 1,579 734 783 262 293
100510
Table 1.56B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Demographic Characteristics: Percentages, 2008 and 2009
Demographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 24.4 24.3 12.0 11.9 4.6 4.8
GENDER            
Male 26.5 26.3 13.1 13.5 5.0 5.5
Female 22.3 22.2 10.8 10.3 4.1 4.0
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 25.8 25.7 12.8 12.6 5.0 5.0
White 29.4 29.8 14.4 14.6 5.4 5.8
Black or African American 14.2 13.5 7.8 6.3 3.5 2.4
American Indian or Alaska Native 25.3 33.6 12.2 19.5 5.8 12.3
Native Hawaiian or Other Pacific Islander * * * * * *
Asian 12.7a 8.1 6.5 4.6 2.4 1.9
Two or More Races 28.9 27.3 14.0 11.0 7.1 3.7
Hispanic or Latino 17.7 18.0 8.0 8.9 2.7 3.8
EDUCATION            
< High School 26.5 26.7 13.7 13.5 5.8 6.3
High School Graduate 23.8 24.9 12.2 12.5 5.2 5.1
Some College 25.0 23.8 12.2 11.8 4.1 4.4
College Graduate 22.0 20.7 8.5 8.7 2.6 2.7
CURRENT EMPLOYMENT            
Full-Time 26.4 25.4 12.4 11.7 5.0 4.8
Part-Time 21.9 23.3 10.7 11.9 3.8a 4.7
Unemployed 27.8 27.5 14.5 14.4 5.6 6.0
Other1 21.5 21.7 11.6 10.8 4.1 4.0
100510
Table 1.57A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Numbers in Thousands, 2008 and 2009
Demographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 24,473 24,513 6,336 6,789 2,678 3,004
GENDER            
Male 13,452 13,751 3,472 3,840 1,387 1,748
Female 11,022 10,762 2,864 2,948 1,292 1,256
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 21,947 22,120 5,686 5,977 2,422 2,739
White 18,941 19,335 4,804 5,089 2,069 2,233
Black or African American 2,072 1,716 607 532 254 260
American Indian or Alaska Native 83 * 27 * 12 *
Native Hawaiian or Other Pacific Islander * * * * * *
Asian 457 405 140 140 56 102
Two or More Races 302 368 55 102 24 55
Hispanic or Latino 2,526 2,393 649 811 257 265
EDUCATION            
< High School 3,369 3,363 918 1,218 441 652
High School Graduate 7,705 7,322 2,062 2,139 830 994
Some College 7,139 6,901 1,920 1,714 926 751
College Graduate 6,260 6,927 1,436 1,717 481 607
CURRENT EMPLOYMENT            
Full-Time 16,200 15,023 3,974 3,739 1,477 1,481
Part-Time 3,112 3,013 699 836 299 330
Unemployed 1,208b 2,070 554 683 245 309
Other1 3,953 4,406 1,108a 1,530 657 884
100510
Table 1.57B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Percentages, 2008 and 2009
Demographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 12.7 12.7 3.3 3.5 1.4 1.6
GENDER            
Male 14.6 14.8 3.8 4.1 1.5 1.9
Female 11.0 10.7 2.9 2.9 1.3 1.2
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 13.1 13.1 3.4 3.5 1.4 1.6
White 14.1 14.3 3.6 3.8 1.5 1.7
Black or African American 9.8 8.0 2.9 2.5 1.2 1.2
American Indian or Alaska Native 10.7 * 3.5 * 1.5 *
Native Hawaiian or Other Pacific Islander * * * * * *
Asian 5.5 4.8 1.7 1.6 0.7 1.2
Two or More Races 14.4 18.4 2.6 5.1 1.2 2.7
Hispanic or Latino 10.3 9.6 2.6 3.2 1.0 1.1
EDUCATION            
< High School 11.6 11.8 3.1 4.3 1.5 2.3
High School Graduate 13.2 12.6 3.5 3.7 1.4 1.7
Some College 15.4 14.8 4.1 3.7 2.0 1.6
College Graduate 10.8 11.5 2.5 2.9 0.8 1.0
CURRENT EMPLOYMENT            
Full-Time 15.1 14.7 3.7 3.7 1.4 1.4
Part-Time 14.4 13.4 3.2 3.7 1.4 1.5
Unemployed 20.4 20.3 9.4 6.7 4.1 3.0
Other1 6.9 7.5 1.9a 2.6 1.2 1.5
100510
Table 1.58A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Numbers in Thousands, 2008 and 2009
Demographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 32,515 32,669 10,277 10,789 4,180 4,604
GENDER            
Male 17,849 18,195 5,645 6,115 2,219a 2,676
Female 14,666 14,473 4,632 4,674 1,961 1,928
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 28,962 29,172 9,164 9,434 3,767 4,108
White 24,913 25,406 7,720 8,070 3,171 3,409
Black or African American 2,732 2,363 969 837 419 376
American Indian or Alaska Native 126a 308 48 112 22 70
Native Hawaiian or Other Pacific Islander * * * * 10 *
Asian 647 528 238 210 92 130
Two or More Races 421 485 112 149 54 71
Hispanic or Latino 3,553 3,497 1,113 1,355 413 496
EDUCATION            
< High School 4,927 4,987 1,722 2,039 780a 1,037
High School Graduate 10,468 10,245 3,483 3,608 1,429 1,597
Some College 9,853 9,533 3,246 3,016 1,373 1,236
College Graduate 7,267 7,903 1,826 2,126 598 734
CURRENT EMPLOYMENT            
Full-Time 20,151b 18,163 5,827a 5,184 2,221 2,075
Part-Time 4,986 5,199 1,611a 1,953 624 769
Unemployed 2,059b 3,322 998b 1,338 415a 583
Other1 5,318 5,986 1,842a 2,313 919 1,176
100510
Table 1.58B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, 2008 and 2009
Demographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 14.5 14.4 4.6 4.7 1.9 2.0
GENDER            
Male 16.4 16.6 5.2 5.6 2.0a 2.4
Female 12.6 12.3 4.0 4.0 1.7 1.6
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 14.9 14.9 4.7 4.8 1.9 2.1
White 16.1 16.3 5.0 5.2 2.0 2.2
Black or African American 10.6 9.0 3.8 3.2 1.6 1.4
American Indian or Alaska Native 13.3a 28.2 5.1 10.3 2.3 6.4
Native Hawaiian or Other Pacific Islander * * * * 1.3 *
Asian 6.6 5.3 2.4 2.1 0.9 1.3
Two or More Races 16.8 20.0 4.5 6.1 2.1 2.9
Hispanic or Latino 11.7 11.2 3.7 4.4 1.4 1.6
EDUCATION            
< High School 14.1 14.4 4.9 5.9 2.2a 3.0
High School Graduate 14.9 14.6 5.0 5.1 2.0 2.3
Some College 17.2 16.5 5.7 5.2 2.4 2.1
College Graduate 11.6 12.2 2.9 3.3 1.0 1.1
CURRENT EMPLOYMENT            
Full-Time 16.5 15.8 4.8 4.5 1.8 1.8
Part-Time 16.5 16.4 5.3 6.1 2.1 2.4
Unemployed 22.9 22.5 11.1 9.1 4.6 4.0
Other1 8.4 9.1 2.9 3.5 1.4 1.8
120405
Table 1.59A (REVISED) – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, based on data from original questions not including methamphetamine items added in 2005 and 2006.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 117,815 119,259 35,643b 38,123 20,123b 21,930
GEOGRAPHIC DIVISION            
Northeast 21,840 22,413 6,310b 7,480 3,812a 4,375
New England 6,308 6,625 1,859b 2,370 1,200 1,452
Middle Atlantic 15,532 15,789 4,451a 5,110 2,612 2,923
Midwest 26,107 26,718 7,505 7,666 4,172 4,353
East North Central 18,348 18,818 5,511 5,563 3,136 3,191
West North Central 7,759 7,900 1,994 2,104 1,036 1,162
South 40,988 41,016 12,049 12,731 6,450a 7,209
South Atlantic 22,591 22,827 6,676 6,978 3,588 4,006
East South Central 6,117 6,445 1,882 1,815 1,067 1,041
West South Central 12,280 11,743 3,491 3,938 1,796a 2,162
West 28,880 29,112 9,779 10,246 5,688 5,993
Mountain 8,742 8,921 2,777 2,971 1,625 1,696
Pacific 20,137 20,191 7,002 7,275 4,063 4,297
COUNTY TYPE            
Large Metro 63,996 64,271 19,965 21,025 11,361 12,133
Small Metro 35,691 37,003 10,708a 11,839 6,158 6,783
250K - 1 Mil. Pop. 23,821 24,841 7,102a 7,876 4,255 4,491
< 250K Pop. 11,870 12,162 3,606 3,963 1,903a 2,291
Nonmetro 18,127 17,986 4,969 5,259 2,605 3,015
Urbanized 8,123 8,164 2,267 2,480 1,237 1,430
Less Urbanized 8,416 8,189 2,325 2,389 1,122 1,392
Completely Rural 1,588 1,633 377 390 245 193
120405
Table 1.59B (REVISED) – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, based on data from original questions not including methamphetamine items added in 2005 and 2006.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 47.2 47.4 14.3b 15.1 8.1b 8.7
GEOGRAPHIC DIVISION            
Northeast 47.4 48.3 13.7b 16.1 8.3a 9.4
New England 52.3 54.4 15.4b 19.5 10.0 11.9
Middle Atlantic 45.6 46.2 13.1a 14.9 7.7 8.5
Midwest 47.5 48.4 13.7 13.9 7.6 7.9
East North Central 47.8 48.9 14.4 14.5 8.2 8.3
West North Central 46.8 47.3 12.0 12.6 6.3 7.0
South 45.1 44.6 13.2 13.8 7.1 7.8
South Atlantic 47.1 47.0 13.9 14.4 7.5 8.2
East South Central 41.2 43.0 12.7 12.1 7.2 6.9
West South Central 43.7 41.2 12.4 13.8 6.4a 7.6
West 50.0 50.0 16.9 17.6 9.8 10.3
Mountain 49.7 50.1 15.8 16.7 9.2 9.5
Pacific 50.1 50.0 17.4 18.0 10.1 10.6
COUNTY TYPE            
Large Metro 48.1 48.0 15.0 15.7 8.5 9.1
Small Metro 47.3 48.2 14.2a 15.4 8.2 8.8
250K - 1 Mil. Pop. 47.6 49.1 14.2 15.6 8.5 8.9
< 250K Pop. 46.6 46.6 14.2 15.2 7.5 8.8
Nonmetro 43.9 43.6 12.0 12.7 6.3a 7.3
Urbanized 47.3 45.2 13.2 13.7 7.2 7.9
Less Urbanized 42.0 43.0 11.6 12.6 5.6b 7.3
Completely Rural 39.4 39.0 9.4 9.3 6.1 4.6
120405
Table 1.60A (REVISED) – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Numbers in Thousands, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, based on data from original questions not including methamphetamine items added in 2005 and 2006.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 6,565 6,629 4,751 4,838 2,312 2,484
GEOGRAPHIC DIVISION            
Northeast 1,080 1,063 822 825 459 447
New England 291 302 220 241 122 141
Middle Atlantic 789 761 602 584 337 306
Midwest 1,374 1,422 1,015 1,020 501 557
East North Central 993 1,045 734 771 375 432
West North Central 381 377 281 249 126 125
South 2,365 2,385 1,618 1,686 719 796
South Atlantic 1,325 1,239 906 888 405 407
East South Central 331a 390 215b 286 94a 129
West South Central 709 756 497 512 220 260
West 1,746 1,758 1,297 1,308 633 684
Mountain 554 515 409 386 211 191
Pacific 1,193 1,243 888 922 422 493
COUNTY TYPE            
Large Metro 3,425 3,521 2,534 2,574 1,241 1,322
Small Metro 2,064 2,120 1,455 1,552 746 819
250K - 1 Mil. Pop. 1,405 1,426 1,000 1,061 495 573
< 250K Pop. 659 694 455 491 252 246
Nonmetro 1,075 987 762 711 325 343
Urbanized 491 447 365 334 159 163
Less Urbanized 499 456 344 322 139 154
Completely Rural 85 84 53 55 26 25
120405
Table 1.60B (REVISED) – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Percentages, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, based on data from original questions not including methamphetamine items added in 2005 and 2006.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 26.4 26.9 19.1 19.7 9.3a 10.1
GEOGRAPHIC DIVISION            
Northeast 24.7 24.7 18.8 19.2 10.5 10.4
New England 25.7 27.1 19.4 21.6 10.8 12.7
Middle Atlantic 24.3 23.8 18.6 18.3 10.4 9.6
Midwest 24.9 26.3 18.4 18.8 9.1 10.3
East North Central 25.7 27.6 19.0 20.3 9.7a 11.4
West North Central 23.2 23.2 17.1 15.4 7.7 7.7
South 26.1 26.5 17.9 18.7 7.9 8.8
South Atlantic 29.0 27.3 19.8 19.6 8.9 9.0
East South Central 22.5a 26.8 14.6b 19.6 6.4a 8.8
West South Central 23.6 25.1 16.5 17.0 7.3 8.6
West 29.3 29.9 21.8 22.2 10.6 11.6
Mountain 30.6 28.6 22.6 21.4 11.7 10.6
Pacific 28.7 30.5 21.4 22.6 10.2 12.1
COUNTY TYPE            
Large Metro 25.8 27.0 19.0 19.8 9.3 10.1
Small Metro 27.9 27.6 19.6 20.2 10.1 10.7
250K - 1 Mil. Pop. 28.7 27.9 20.4 20.7 10.1 11.2
< 250K Pop. 26.3 27.2 18.1 19.2 10.0 9.6
Nonmetro 25.7 25.3 18.2 18.2 7.8 8.8
Urbanized 27.5 26.1 20.4 19.5 8.9 9.5
Less Urbanized 24.8 25.3 17.1 17.9 6.9 8.6
Completely Rural 22.6 21.6 14.1 14.2 6.8 6.5
120405
Table 1.61A (REVISED) – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Numbers in Thousands, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, based on data from original questions not including methamphetamine items added in 2005 and 2006.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 18,772b 19,658 11,090b 12,186 6,490b 7,176
GEOGRAPHIC DIVISION            
Northeast 3,600 3,762 2,243b 2,554 1,421 1,555
New England 982b 1,102 631b 769 407 477
Middle Atlantic 2,618 2,659 1,611a 1,785 1,015 1,078
Midwest 4,213 4,354 2,414 2,558 1,370 1,444
East North Central 2,901b 3,093 1,707a 1,850 984 1,063
West North Central 1,312 1,261 707 708 385 382
South 6,377b 6,742 3,609a 3,947 2,064a 2,333
South Atlantic 3,276a 3,497 1,898a 2,112 1,075 1,215
East South Central 970 1,053 562 606 350 348
West South Central 2,131 2,193 1,150 1,229 638a 770
West 4,581 4,799 2,824b 3,128 1,635a 1,845
Mountain 1,452 1,419 814 854 484 517
Pacific 3,129a 3,380 2,010a 2,274 1,151a 1,328
COUNTY TYPE            
Large Metro 10,081 10,471 6,086a 6,623 3,584a 3,884
Small Metro 5,904 6,227 3,485a 3,884 2,045a 2,343
250K - 1 Mil. Pop. 3,788 3,966 2,207 2,443 1,294 1,441
< 250K Pop. 2,116 2,261 1,278 1,441 750 903
Nonmetro 2,787 2,960 1,519 1,678 861 949
Urbanized 1,350 1,486 741 855 404 494
Less Urbanized 1,263 1,288 688 720 399 393
Completely Rural 174 186 90 103 58 62
120405
Table 1.61B (REVISED) – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Percentages, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, based on data from original questions not including methamphetamine items added in 2005 and 2006.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 57.0a 58.5 33.7b 36.3 19.7b 21.4
GEOGRAPHIC DIVISION            
Northeast 60.1 61.5 37.5b 41.7 23.7 25.4
New England 63.1a 69.0 40.6b 48.1 26.1 29.9
Middle Atlantic 59.1 58.8 36.4 39.5 22.9 23.8
Midwest 57.9 59.3 33.2 34.9 18.8 19.7
East North Central 57.6a 60.9 33.9 36.4 19.6 20.9
West North Central 58.6 55.8 31.6 31.3 17.2 16.9
South 54.2 56.1 30.7 32.8 17.5a 19.4
South Atlantic 54.9 57.2 31.8 34.5 18.0 19.9
East South Central 51.8 55.4 30.0 31.9 18.7 18.3
West South Central 54.3 54.7 29.3 30.7 16.3a 19.2
West 57.9 59.3 35.7a 38.6 20.7 22.8
Mountain 61.3 58.6 34.3 35.3 20.4 21.4
Pacific 56.5 59.5 36.3a 40.0 20.8 23.4
COUNTY TYPE            
Large Metro 56.5a 58.7 34.1b 37.1 20.1a 21.8
Small Metro 58.5 59.4 34.5a 37.0 20.2a 22.3
250K - 1 Mil. Pop. 57.9 59.3 33.7a 36.5 19.8 21.5
< 250K Pop. 59.5 59.4 35.9 37.9 21.1 23.7
Nonmetro 55.8 56.5 30.4 32.0 17.2 18.1
Urbanized 59.1 59.1 32.4 34.0 17.7 19.7
Less Urbanized 53.7 53.6 29.2 30.0 16.9 16.3
Completely Rural 48.9 57.2 25.4 31.8 16.2 19.1
120405
Table 1.62A (REVISED) – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Numbers in Thousands, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, based on data from original questions not including methamphetamine items added in 2005 and 2006.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 92,478 92,973 19,801 21,099 11,321 12,270
GEOGRAPHIC DIVISION            
Northeast 17,160 17,588 3,245b 4,102 1,932 2,373
New England 5,035 5,220 1,008a 1,360 672 834
Middle Atlantic 12,125 12,368 2,237 2,741 1,260 1,540
Midwest 20,520 20,942 4,076 4,089 2,302 2,352
East North Central 14,454 14,679 3,069 2,942 1,777 1,696
West North Central 6,066 6,263 1,006 1,147 525 655
South 32,245 31,888 6,822 7,098 3,668 4,080
South Atlantic 17,991 18,092 3,872 3,978 2,108 2,384
East South Central 4,815 5,002 1,105 923 622 565
West South Central 9,440 8,794 1,845 2,197 938 1,131
West 22,552 22,555 5,659 5,811 3,420 3,465
Mountain 6,737 6,987 1,555 1,731 930 989
Pacific 15,815 15,568 4,103 4,080 2,490 2,476
COUNTY TYPE            
Large Metro 50,490 50,279 11,346 11,827 6,535 6,926
Small Metro 27,723 28,656 5,768 6,403 3,367 3,621
250K - 1 Mil. Pop. 18,628 19,450 3,895 4,372 2,466 2,478
< 250K Pop. 9,095 9,206 1,873 2,031 901 1,143
Nonmetro 14,265 14,038 2,688 2,870 1,420 1,723
Urbanized 6,283 6,231 1,160 1,291 674 773
Less Urbanized 6,653 6,445 1,293 1,347 584a 845
Completely Rural 1,329 1,363 234 232 162 106
120405
Table 1.62B (REVISED) – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Percentages, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, based on data from original questions not including methamphetamine items added in 2005 and 2006.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 48.2 48.0 10.3 10.9 5.9 6.3
GEOGRAPHIC DIVISION            
Northeast 48.0 48.9 9.1b 11.4 5.4 6.6
New England 53.7 55.1 10.8a 14.4 7.2 8.8
Middle Atlantic 46.0 46.7 8.5 10.3 4.8 5.8
Midwest 48.7 49.4 9.7 9.6 5.5 5.5
East North Central 49.0 49.6 10.4 9.9 6.0 5.7
West North Central 47.8 48.9 7.9 8.9 4.1 5.1
South 46.0 44.9 9.7 10.0 5.2 5.7
South Atlantic 48.0 47.7 10.3 10.5 5.6 6.3
East South Central 41.8 43.0 9.6 7.9 5.4 4.9
West South Central 44.6 41.0 8.7 10.2 4.4 5.3
West 51.3 51.0 12.9 13.1 7.8 7.8
Mountain 50.2 51.4 11.6 12.7 6.9 7.3
Pacific 51.8 50.8 13.4 13.3 8.2 8.1
COUNTY TYPE            
Large Metro 49.5 48.8 11.1 11.5 6.4 6.7
Small Metro 47.8 48.9 10.0 10.9 5.8 6.2
250K - 1 Mil. Pop. 48.3 50.1 10.1 11.3 6.4 6.4
< 250K Pop. 46.9 46.6 9.6 10.3 4.6 5.8
Nonmetro 44.5 43.7 8.4 8.9 4.4 5.4
Urbanized 48.0 45.1 8.9 9.3 5.1 5.6
Less Urbanized 42.4 43.5 8.2 9.1 3.7a 5.7
Completely Rural 40.3 39.2 7.1 6.7 4.9 3.0
120405
Table 1.63A (REVISED) – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Numbers in Thousands, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, based on data from original questions not including methamphetamine items added in 2005 and 2006.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 111,250 112,631 30,892b 33,285 17,811b 19,446
GEOGRAPHIC DIVISION            
Northeast 20,760 21,350 5,488b 6,655 3,353a 3,928
New England 6,017 6,323 1,639b 2,129 1,078 1,311
Middle Atlantic 14,743 15,027 3,848a 4,526 2,275 2,617
Midwest 24,733 25,296 6,490 6,647 3,672 3,796
East North Central 17,355 17,773 4,777 4,792 2,761 2,759
West North Central 7,378 7,524 1,714 1,855 911 1,037
South 38,623 38,631 10,431 11,045 5,731a 6,413
South Atlantic 21,267 21,588 5,770 6,089 3,183 3,599
East South Central 5,785 6,055 1,667 1,529 973 913
West South Central 11,571 10,987 2,994 3,426 1,576a 1,902
West 27,133 27,354 8,482 8,938 5,055 5,310
Mountain 8,189 8,406 2,369 2,585 1,414 1,505
Pacific 18,945 18,948 6,114 6,354 3,641 3,804
COUNTY TYPE            
Large Metro 60,571 60,749 17,432 18,450 10,119 10,810
Small Metro 33,627 34,883 9,253a 10,287 5,412 5,964
250K - 1 Mil. Pop. 22,416 23,415 6,102 6,815 3,761 3,919
< 250K Pop. 11,211 11,467 3,151 3,472 1,651a 2,045
Nonmetro 17,052 16,999 4,207 4,548 2,280 2,672
Urbanized 7,632 7,717 1,901 2,145 1,078 1,267
Less Urbanized 7,917 7,733 1,981 2,067 983 1,238
Completely Rural 1,503 1,549 324 335 220 168
120405
Table 1.63B (REVISED) – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Percentages, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, based on data from original questions not including methamphetamine items added in 2005 and 2006.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 49.5 49.6 13.7b 14.6 7.9a 8.6
GEOGRAPHIC DIVISION            
Northeast 49.8 50.7 13.2b 15.8 8.0a 9.3
New England 55.1 57.1 15.0b 19.2 9.9 11.8
Middle Atlantic 47.9 48.5 12.5a 14.6 7.4 8.4
Midwest 50.0 50.8 13.1 13.4 7.4 7.6
East North Central 50.3 51.3 13.8 13.8 8.0 8.0
West North Central 49.4 49.9 11.5 12.3 6.1 6.9
South 47.2 46.5 12.7 13.3 7.0 7.7
South Atlantic 49.0 49.0 13.3 13.8 7.3 8.2
East South Central 43.2 44.7 12.4 11.3 7.3 6.7
West South Central 46.1 43.1 11.9 13.4 6.3 7.5
West 52.3 52.3 16.4 17.1 9.8 10.1
Mountain 51.9 52.5 15.0 16.1 9.0 9.4
Pacific 52.5 52.2 17.0 17.5 10.1 10.5
COUNTY TYPE            
Large Metro 50.6 50.3 14.6 15.3 8.4 8.9
Small Metro 49.4 50.5 13.6a 14.9 8.0 8.6
250K - 1 Mil. Pop. 49.7 51.4 13.5 15.0 8.3 8.6
< 250K Pop. 48.8 48.7 13.7 14.7 7.2a 8.7
Nonmetro 46.0 45.5 11.3 12.2 6.2 7.2
Urbanized 49.6 47.3 12.4 13.1 7.0 7.8
Less Urbanized 43.9 44.9 11.0 12.0 5.4a 7.2
Completely Rural 41.2 40.8 8.9 8.8 6.0 4.4
120405
Table 1.64A (REVISED) – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 102,857 104,950 25,891b 28,688 15,269b 16,826
GEOGRAPHIC DIVISION            
Northeast 19,406 20,431 4,854b 6,133 2,910b 3,593
New England 5,778 6,216 1,470b 2,007 918b 1,242
Middle Atlantic 13,628 14,215 3,384b 4,126 1,992a 2,352
Midwest 23,071 23,836 5,389 5,842 3,148 3,428
East North Central 16,263 16,853 3,992 4,177 2,364 2,460
West North Central 6,808 6,982 1,397 1,665 783 968
South 35,422 35,155 8,522 9,023 4,825 5,192
South Atlantic 19,814 19,456 4,895 5,127 2,730 3,013
East South Central 5,183 5,597 1,303 1,279 774 692
West South Central 10,426 10,101 2,323 2,617 1,322 1,486
West 24,959 25,529 7,126 7,690 4,386 4,613
Mountain 7,473 7,801 2,001 2,119 1,280 1,263
Pacific 17,486 17,728 5,125 5,571 3,106 3,350
COUNTY TYPE            
Large Metro 55,558 56,797 14,746a 16,168 8,661 9,455
Small Metro 31,365 32,521 7,726b 8,744 4,651 5,210
250K - 1 Mil. Pop. 20,951 21,819 5,176 5,743 3,144 3,450
< 250K Pop. 10,414 10,702 2,550a 3,001 1,507 1,760
Nonmetro 15,934 15,632 3,419 3,776 1,956 2,162
Urbanized 7,221 7,182 1,603 1,766 923 1,017
Less Urbanized 7,324 7,025 1,512 1,729 821 1,006
Completely Rural 1,389 1,425 304 281 213 139
120405
Table 1.64B (REVISED) – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 41.2 41.7 10.4b 11.4 6.1b 6.7
GEOGRAPHIC DIVISION            
Northeast 42.1 44.0 10.5b 13.2 6.3b 7.7
New England 47.9 51.0 12.2b 16.5 7.6b 10.2
Middle Atlantic 40.0 41.6 9.9b 12.1 5.9 6.9
Midwest 42.0 43.2 9.8 10.6 5.7 6.2
East North Central 42.4 43.8 10.4 10.9 6.2 6.4
West North Central 41.1 41.8 8.4 10.0 4.7 5.8
South 38.9 38.2 9.4 9.8 5.3 5.6
South Atlantic 41.3 40.1 10.2 10.6 5.7 6.2
East South Central 34.9 37.3 8.8 8.5 5.2 4.6
West South Central 37.1 35.5 8.3 9.2 4.7 5.2
West 43.2 43.9 12.3 13.2 7.6 7.9
Mountain 42.5 43.8 11.4 11.9 7.3 7.1
Pacific 43.5 43.9 12.7 13.8 7.7 8.3
COUNTY TYPE            
Large Metro 41.7 42.4 11.1a 12.1 6.5 7.1
Small Metro 41.6 42.4 10.2a 11.4 6.2 6.8
250K - 1 Mil. Pop. 41.9 43.1 10.4 11.3 6.3 6.8
< 250K Pop. 40.9 41.0 10.0 11.5 5.9 6.7
Nonmetro 38.6 37.9 8.3 9.2 4.7 5.2
Urbanized 42.1 39.8 9.3 9.8 5.4 5.6
Less Urbanized 36.5 36.9 7.5a 9.1 4.1a 5.3
Completely Rural 34.5 34.0 7.6 6.7 5.3 3.3
120405
Table 1.65A (REVISED) – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Numbers in Thousands, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 4,138 4,204 3,258 3,363 1,668 1,813
GEOGRAPHIC DIVISION            
Northeast 724 735 614 635 367 365
New England 208 226 176 198 106 114
Middle Atlantic 516 509 438 437 261 250
Midwest 876 928 689 733 362 413
East North Central 639 692 500 559 273 325
West North Central 236 236 189 174 89 89
South 1,399 1,382 1,048 1,071 476 535
South Atlantic 814 731 636 571 273 280
East South Central 194 188 127 139 58 63
West South Central 390 464 284a 362 145 192
West 1,139 1,159 907 923 462 500
Mountain 354 349 291 278 154 156
Pacific 785 809 616 646 309 345
COUNTY TYPE            
Large Metro 2,180 2,249 1,761 1,829 899 973
Small Metro 1,328 1,343 1,032 1,066 554 619
250K - 1 Mil. Pop. 922 952 717 773 371 447
< 250K Pop. 406 390 315 292 183 173
Nonmetro 630 612 464 468 215 221
Urbanized 310 286 230 217 110 108
Less Urbanized 273 278 203 217 92 98
Completely Rural 46 48 31 34 13 15
120405
Table 1.65B (REVISED) – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Percentages, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 16.6 17.1 13.1 13.7 6.7a 7.4
GEOGRAPHIC DIVISION            
Northeast 16.5 17.1 14.0 14.7 8.4 8.5
New England 18.4 20.3 15.6 17.8 9.4 10.3
Middle Atlantic 15.9 15.9 13.5 13.7 8.1 7.8
Midwest 15.9 17.1 12.5 13.5 6.6 7.6
East North Central 16.5 18.2 12.9a 14.7 7.1a 8.6
West North Central 14.4 14.6 11.5 10.7 5.4 5.5
South 15.5 15.3 11.6 11.9 5.3 5.9
South Atlantic 17.8 16.1 13.9 12.6 6.0 6.2
East South Central 13.2 12.9 8.6 9.6 3.9 4.3
West South Central 13.0 15.4 9.5a 12.0 4.8 6.4
West 19.1 19.7 15.2 15.7 7.8 8.5
Mountain 19.6 19.4 16.1 15.4 8.5 8.6
Pacific 18.9 19.8 14.8 15.8 7.4 8.5
COUNTY TYPE            
Large Metro 16.4 17.3 13.2 14.0 6.8 7.5
Small Metro 17.9 17.5 13.9 13.9 7.5 8.1
250K - 1 Mil. Pop. 18.8 18.6 14.6 15.1 7.6 8.7
< 250K Pop. 16.2 15.3 12.6 11.4 7.3 6.8
Nonmetro 15.1 15.7 11.1 12.0 5.1 5.7
Urbanized 17.3 16.7 12.9 12.6 6.1 6.3
Less Urbanized 13.5 15.5 10.1 12.0 4.6 5.4
Completely Rural 12.3 12.3 8.3 8.9 3.5 3.9
120405
Table 1.66A (REVISED) – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Numbers in Thousands, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 16,718b 17,677 9,154b 10,343 5,459b 6,128
GEOGRAPHIC DIVISION            
Northeast 3,311 3,479 1,951b 2,293 1,246 1,375
New England 922a 1,021 568b 693 365 426
Middle Atlantic 2,389 2,459 1,383b 1,601 881 949
Midwest 3,789 3,893 1,994a 2,165 1,176 1,241
East North Central 2,617a 2,775 1,410b 1,583 824 910
West North Central 1,172 1,118 584 582 352 331
South 5,517b 5,999 2,841b 3,248 1,671a 1,934
South Atlantic 2,881a 3,148 1,543a 1,783 883 1,043
East South Central 834 903 449 472 289 275
West South Central 1,803a 1,948 849a 993 498a 616
West 4,101 4,305 2,369a 2,636 1,367a 1,578
Mountain 1,279 1,223 665 697 396 413
Pacific 2,821a 3,082 1,704a 1,939 971a 1,164
COUNTY TYPE            
Large Metro 8,968 9,461 5,090b 5,729 3,051b 3,419
Small Metro 5,275 5,584 2,845b 3,240 1,702a 1,942
250K - 1 Mil. Pop. 3,390 3,558 1,807 2,002 1,058 1,177
< 250K Pop. 1,885 2,026 1,038 1,238 645 765
Nonmetro 2,475 2,632 1,219 1,374 706 767
Urbanized 1,229 1,346 615 726 341 400
Less Urbanized 1,084 1,113 529 558 313 315
Completely Rural 162 174 76 90 53 52
120405
Table 1.66B (REVISED) – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Percentages, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 50.8b 52.6 27.8b 30.8 16.6b 18.2
GEOGRAPHIC DIVISION            
Northeast 55.3 56.8 32.6b 37.5 20.8 22.5
New England 59.2 63.9 36.5b 43.4 23.5 26.6
Middle Atlantic 53.9 54.4 31.2a 35.4 19.9 21.0
Midwest 52.1 53.1 27.4 29.5 16.2 16.9
East North Central 52.0a 54.7 28.0a 31.2 16.4 17.9
West North Central 52.3 49.5 26.0 25.7 15.7 14.7
South 46.9b 49.9 24.1b 27.0 14.2a 16.1
South Atlantic 48.3 51.5 25.9a 29.2 14.8 17.1
East South Central 44.5 47.5 23.9 24.8 15.4 14.5
West South Central 45.9 48.6 21.6a 24.8 12.7a 15.4
West 51.8 53.2 29.9 32.5 17.3a 19.5
Mountain 54.0 50.5 28.1 28.8 16.7 17.1
Pacific 50.9 54.3 30.7 34.1 17.5a 20.5
COUNTY TYPE            
Large Metro 50.3b 53.0 28.5b 32.1 17.1b 19.2
Small Metro 52.2 53.2 28.2a 30.9 16.9 18.5
250K - 1 Mil. Pop. 51.8 53.2 27.6 29.9 16.2 17.6
< 250K Pop. 53.0 53.3 29.2 32.5 18.1 20.1
Nonmetro 49.6 50.2 24.4 26.2 14.1 14.6
Urbanized 53.8 53.5 26.9 28.9 14.9 15.9
Less Urbanized 46.0 46.3 22.5 23.2 13.3 13.1
Completely Rural 45.7 53.6 21.3 27.7 14.8 15.9
120405
Table 1.67A (REVISED) – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Numbers in Thousands, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 82,001 83,070 13,479a 14,983 8,142 8,885
GEOGRAPHIC DIVISION            
Northeast 15,371 16,216 2,289b 3,205 1,297b 1,854
New England 4,648 4,969 726b 1,116 447b 702
Middle Atlantic 10,723 11,247 1,563a 2,089 850 1,152
Midwest 18,406 19,015 2,706 2,944 1,610 1,773
East North Central 13,006 13,387 2,082 2,035 1,267 1,225
West North Central 5,400 5,628 625a 909 343a 548
South 28,506 27,774 4,633 4,703 2,678 2,723
South Atlantic 16,119 15,578 2,716 2,773 1,574 1,691
East South Central 4,154 4,506 727 668 427 354
West South Central 8,233 7,690 1,190 1,262 678 678
West 19,719 20,065 3,850 4,130 2,557 2,535
Mountain 5,839 6,229 1,045 1,144 731 694
Pacific 13,879 13,837 2,806 2,986 1,826 1,841
COUNTY TYPE            
Large Metro 44,410 45,087 7,894 8,610 4,710 5,063
Small Metro 24,762 25,595 3,849 4,439 2,396 2,649
250K - 1 Mil. Pop. 16,638 17,309 2,652 2,968 1,715 1,827
< 250K Pop. 8,123 8,286 1,197 1,471 680 822
Nonmetro 12,830 12,388 1,736 1,934 1,036 1,173
Urbanized 5,682 5,551 758 823 473 509
Less Urbanized 5,967 5,634 780 955 416 593
Completely Rural 1,180 1,203 198 157 147 72
120405
Table 1.67B (REVISED) – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Percentages, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 42.7 42.9 7.0a 7.7 4.2 4.6
GEOGRAPHIC DIVISION            
Northeast 43.0 45.1 6.4b 8.9 3.6b 5.2
New England 49.6 52.5 7.7b 11.8 4.8b 7.4
Middle Atlantic 40.7 42.5 5.9a 7.9 3.2 4.3
Midwest 43.6 44.8 6.4 6.9 3.8 4.2
East North Central 44.1 45.2 7.1 6.9 4.3 4.1
West North Central 42.5 43.9 4.9a 7.1 2.7 4.3
South 40.6 39.1 6.6 6.6 3.8 3.8
South Atlantic 43.0 41.1 7.2 7.3 4.2 4.5
East South Central 36.1 38.7 6.3 5.7 3.7 3.0
West South Central 38.9 35.8 5.6 5.9 3.2 3.2
West 44.9 45.4 8.8 9.3 5.8 5.7
Mountain 43.5 45.8 7.8 8.4 5.4 5.1
Pacific 45.5 45.2 9.2 9.7 6.0 6.0
COUNTY TYPE            
Large Metro 43.6 43.8 7.7 8.4 4.6 4.9
Small Metro 42.7 43.7 6.6 7.6 4.1 4.5
250K - 1 Mil. Pop. 43.2 44.6 6.9 7.6 4.4 4.7
< 250K Pop. 41.8 42.0 6.2 7.4 3.5 4.2
Nonmetro 40.0 38.6 5.4 6.0 3.2 3.7
Urbanized 43.4 40.2 5.8 6.0 3.6 3.7
Less Urbanized 38.0 38.0 5.0 6.4 2.7a 4.0
Completely Rural 35.8 34.6 6.0 4.5 4.5 2.1
120405
Table 1.68A (REVISED) – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Numbers in Thousands, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 98,720 100,747 22,633b 25,325 13,601b 15,013
GEOGRAPHIC DIVISION            
Northeast 18,682 19,695 4,240b 5,498 2,543b 3,229
New England 5,570 5,990 1,294b 1,809 812b 1,127
Middle Atlantic 13,112 13,705 2,946b 3,689 1,731a 2,101
Midwest 22,195 22,908 4,700 5,109 2,786 3,015
East North Central 15,623 16,162 3,492 3,618 2,091 2,135
West North Central 6,572 6,746 1,208 1,491 694 879
South 34,023 33,773 7,474 7,952 4,349 4,657
South Atlantic 18,999 18,726 4,259 4,556 2,457 2,734
East South Central 4,988 5,409 1,176 1,140 716 629
West South Central 10,035 9,638 2,039 2,256 1,177 1,294
West 23,819 24,371 6,219 6,766 3,924 4,113
Mountain 7,119 7,452 1,710 1,842 1,126 1,107
Pacific 16,701 16,919 4,509 4,925 2,797 3,005
COUNTY TYPE            
Large Metro 53,378 54,548 12,984a 14,339 7,762 8,482
Small Metro 30,037 31,179 6,694b 7,678 4,098 4,591
250K - 1 Mil. Pop. 20,029 20,867 4,459 4,970 2,773 3,004
< 250K Pop. 10,008 10,312 2,235a 2,708 1,325 1,587
Nonmetro 15,304 15,020 2,955 3,308 1,742 1,941
Urbanized 6,911 6,896 1,373 1,549 814 909
Less Urbanized 7,051 6,746 1,309 1,512 729 908
Completely Rural 1,343 1,377 273 247 200 123
120405
Table 1.68B (REVISED) – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Percentages, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 43.9 44.3 10.1b 11.1 6.0a 6.6
GEOGRAPHIC DIVISION            
Northeast 44.8 46.8 10.2b 13.1 6.1b 7.7
New England 51.0 54.1 11.8b 16.3 7.4b 10.2
Middle Atlantic 42.6 44.2 9.6b 11.9 5.6a 6.8
Midwest 44.9 46.0 9.5 10.3 5.6 6.1
East North Central 45.3 46.6 10.1 10.4 6.1 6.2
West North Central 44.0 44.7 8.1 9.9 4.6 5.8
South 41.5 40.7 9.1 9.6 5.3 5.6
South Atlantic 43.7 42.5 9.8 10.3 5.7 6.2
East South Central 37.2 40.0 8.8 8.4 5.3 4.6
West South Central 40.0 37.8 8.1 8.9 4.7 5.1
West 45.9 46.6 12.0 12.9 7.6 7.9
Mountain 45.1 46.5 10.8 11.5 7.1 6.9
Pacific 46.3 46.6 12.5 13.6 7.8 8.3
COUNTY TYPE            
Large Metro 44.6 45.2 10.8a 11.9 6.5 7.0
Small Metro 44.1 45.1 9.8a 11.1 6.0 6.6
250K - 1 Mil. Pop. 44.4 45.8 9.9 10.9 6.1 6.6
< 250K Pop. 43.6 43.8 9.7a 11.5 5.8 6.7
Nonmetro 41.3 40.2 8.0 8.9 4.7 5.2
Urbanized 44.9 42.2 8.9 9.5 5.3 5.6
Less Urbanized 39.1 39.2 7.3a 8.8 4.0a 5.3
Completely Rural 36.8 36.3 7.5 6.5 5.5 3.2
120405
Table 1.69A (REVISED) – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 36,916 36,742 5,283 4,806 1,865 1,642
GEOGRAPHIC DIVISION            
Northeast 6,796 7,353 1,074 1,126 456 415
New England 2,167 2,472 254 354 93 158
Middle Atlantic 4,629 4,881 821 772 363 257
Midwest 7,477 7,181 1,105b 827 374 261
East North Central 5,255 4,955 821a 604 284 204
West North Central 2,222 2,226 284 223 90 57
South 12,261 11,352 1,727 1,592 608 632
South Atlantic 7,168b 5,868 946 918 324 379
East South Central 1,656 1,641 231 153 57 52
West South Central 3,437 3,843 550 521 228 200
West 10,382 10,856 1,377 1,260 427 334
Mountain 3,342 3,204 419 427 122 142
Pacific 7,040 7,652 958 833 304 193
COUNTY TYPE            
Large Metro 20,524 19,917 2,995 2,615 1,117 896
Small Metro 11,132 11,525 1,640 1,609 557 588
250K - 1 Mil. Pop. 7,609 7,685 1,081 1,131 422 473
< 250K Pop. 3,522 3,840 559 478 135 116
Nonmetro 5,260 5,300 648 582 191 157
Urbanized 2,298 2,438 306 280 98a 42
Less Urbanized 2,471 2,456 307 271 79 112
Completely Rural 491 406 34 31 14 3
120405
Table 1.69B (REVISED) – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 14.8 14.6 2.1 1.9 0.7 0.7
GEOGRAPHIC DIVISION            
Northeast 14.7 15.9 2.3 2.4 1.0 0.9
New England 18.0 20.3 2.1 2.9 0.8 1.3
Middle Atlantic 13.6 14.3 2.4 2.3 1.1 0.8
Midwest 13.6 13.0 2.0b 1.5 0.7 0.5
East North Central 13.7 12.9 2.1a 1.6 0.7 0.5
West North Central 13.4 13.3 1.7 1.3 0.5 0.3
South 13.5 12.3 1.9 1.7 0.7 0.7
South Atlantic 14.9b 12.1 2.0 1.9 0.7 0.8
East South Central 11.1 11.0 1.6 1.0 0.4 0.3
West South Central 12.2 13.5 2.0 1.8 0.8 0.7
West 18.0 18.6 2.4 2.2 0.7 0.6
Mountain 19.0 18.0 2.4 2.4 0.7 0.8
Pacific 17.5 18.9 2.4 2.1 0.8 0.5
COUNTY TYPE            
Large Metro 15.4 14.9 2.3 2.0 0.8 0.7
Small Metro 14.7 15.0 2.2 2.1 0.7 0.8
250K - 1 Mil. Pop. 15.2 15.2 2.2 2.2 0.8 0.9
< 250K Pop. 13.8 14.7 2.2 1.8 0.5 0.4
Nonmetro 12.8 12.8 1.6 1.4 0.5 0.4
Urbanized 13.4 13.5 1.8 1.6 0.6a 0.2
Less Urbanized 12.3 12.9 1.5 1.4 0.4 0.6
Completely Rural 12.2 9.7 0.9 0.7 0.3 0.1
120405
Table 1.70A (REVISED) – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Numbers in Thousands, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 473 405 306 242 98 70
GEOGRAPHIC DIVISION            
Northeast 64 56 46 36 17 14
New England 18 15 15 10 5 3
Middle Atlantic 46 41 30 26 11 11
Midwest 98 72 66 47 20 12
East North Central 64 54 46 37 15 9
West North Central 34 17 20 10 4 3
South 163 140 91 75 29 16
South Atlantic 90 58 44 27 12 5
East South Central 13 19 6 15 2 3
West South Central 60 62 42 33 16 7
West 147 138 103 83 32 29
Mountain 64 45 41 25 19b 6
Pacific 83 92 62 58 13 23
COUNTY TYPE            
Large Metro 246 200 167 126 42 33
Small Metro 164 153 105 87 44 27
250K - 1 Mil. Pop. 101 94 75 53 38a 18
< 250K Pop. 63 58 30 34 6 9
Nonmetro 63 52 34 29 12 10
Urbanized 28 26 16 18 6 4
Less Urbanized 29 23 15 11 5 5
Completely Rural 6 3 3 1 1 1
120405
Table 1.70B (REVISED) – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Percentages, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 1.9 1.6 1.2 1.0 0.4 0.3
GEOGRAPHIC DIVISION            
Northeast 1.5 1.3 1.0 0.8 0.4 0.3
New England 1.6 1.3 1.4 0.9 0.5 0.3
Middle Atlantic 1.4 1.3 0.9 0.8 0.3 0.3
Midwest 1.8 1.3 1.2 0.9 0.4 0.2
East North Central 1.7 1.4 1.2 1.0 0.4 0.2
West North Central 2.1 1.1 1.2 0.6 0.3 0.2
South 1.8 1.6 1.0 0.8 0.3 0.2
South Atlantic 2.0 1.3 1.0 0.6 0.3 0.1
East South Central 0.9 1.3 0.4 1.0 0.1 0.2
West South Central 2.0 2.1 1.4 1.1 0.5 0.2
West 2.5 2.3 1.7 1.4 0.5 0.5
Mountain 3.5 2.5 2.3 1.4 1.1b 0.3
Pacific 2.0 2.3 1.5 1.4 0.3 0.6
COUNTY TYPE            
Large Metro 1.8 1.5 1.3 1.0 0.3 0.3
Small Metro 2.2 2.0 1.4 1.1 0.6 0.3
250K - 1 Mil. Pop. 2.1 1.8 1.5 1.0 0.8a 0.3
< 250K Pop. 2.5 2.3 1.2 1.3 0.2 0.4
Nonmetro 1.5 1.3 0.8 0.8 0.3 0.3
Urbanized 1.6 1.5 0.9 1.0 0.3 0.3
Less Urbanized 1.4 1.3 0.8 0.6 0.3 0.3
Completely Rural 1.6 0.7 0.7 0.3 0.2 0.2
120405
Table 1.71A (REVISED) – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Numbers in Thousands, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 4,772 4,997 1,844 1,790 515 466
GEOGRAPHIC DIVISION            
Northeast 859 983 367a 462 136 148
New England 257 309 102a 149 23b 64
Middle Atlantic 602 673 265 313 113 84
Midwest 1,074 992 398 330 94 88
East North Central 720 697 277 240 73 72
West North Central 355 294 121 90 21 15
South 1,492 1,671 545 552 152 117
South Atlantic 741 800 273 296 80 68
East South Central 216 213 78 53 22 9
West South Central 535a 658 193 203 50 40
West 1,347 1,352 534 446 133 113
Mountain 513 487 180 150 51 49
Pacific 834 864 353 296 82 64
COUNTY TYPE            
Large Metro 2,396 2,556 994 944 294 248
Small Metro 1,643 1,666 608 608 160 169
250K - 1 Mil. Pop. 1,070 1,105 380 395 114 122
< 250K Pop. 573 560 229 213 47 47
Nonmetro 734 775 241 238 60 49
Urbanized 341 389 111 131 26 22
Less Urbanized 348 344 120 95 31 24
Completely Rural 44 42 10 12 3 3
120405
Table 1.71B (REVISED) – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Percentages, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 14.5 14.9 5.6 5.3 1.6 1.4
GEOGRAPHIC DIVISION            
Northeast 14.4 16.1 6.1a 7.6 2.3 2.4
New England 16.5 19.4 6.6a 9.3 1.5b 4.0
Middle Atlantic 13.6 14.9 6.0 6.9 2.5 1.9
Midwest 14.8 13.5 5.5 4.5 1.3 1.2
East North Central 14.3 13.7 5.5 4.7 1.4 1.4
West North Central 15.8a 13.0 5.4 4.0 0.9 0.7
South 12.7 13.9 4.6 4.6 1.3 1.0
South Atlantic 12.4 13.1 4.6 4.8 1.3 1.1
East South Central 11.5 11.2 4.2 2.8 1.2 0.5
West South Central 13.6a 16.4 4.9 5.1 1.3 1.0
West 17.0 16.7 6.7 5.5 1.7 1.4
Mountain 21.7 20.1 7.6 6.2 2.2 2.0
Pacific 15.0 15.2 6.4 5.2 1.5 1.1
COUNTY TYPE            
Large Metro 13.4 14.3 5.6 5.3 1.6 1.4
Small Metro 16.3 15.9 6.0 5.8 1.6 1.6
250K - 1 Mil. Pop. 16.4 16.5 5.8 5.9 1.7 1.8
< 250K Pop. 16.1 14.7 6.4 5.6 1.3 1.2
Nonmetro 14.7 14.8 4.8 4.5 1.2 0.9
Urbanized 14.9 15.5 4.9 5.2 1.1 0.9
Less Urbanized 14.8 14.3 5.1 4.0 1.3 1.0
Completely Rural 12.5 13.0 2.9 3.6 0.8 0.8
120405
Table 1.72A (REVISED) – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Numbers in Thousands, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 31,671 31,339 3,133 2,773 1,252 1,106
GEOGRAPHIC DIVISION            
Northeast 5,872 6,314 661 627 304 253
New England 1,892 2,148 136 195 64 91
Middle Atlantic 3,980 4,166 525 432 240 162
Midwest 6,305 6,118 640a 450 261 161
East North Central 4,472 4,204 497a 327 196 123
West North Central 1,833 1,914 143 123 65 39
South 10,606 9,541 1,091 965 427 499
South Atlantic 6,337b 5,009 629 595 232 306
East South Central 1,427 1,409 147 85 33 39
West South Central 2,841 3,123 315 285 162 153
West 8,889 9,366 740 731 262 192
Mountain 2,765 2,671 198 252 52 87
Pacific 6,123 6,695 543 479 210 105
COUNTY TYPE            
Large Metro 17,882 17,161 1,833 1,546 781 615
Small Metro 9,325 9,706 927 913 352 393
250K - 1 Mil. Pop. 6,439 6,485 627 683 270 333
< 250K Pop. 2,886 3,221 300 231 82 59
Nonmetro 4,464 4,473 372 314 119 98
Urbanized 1,929 2,024 179 131 66 15
Less Urbanized 2,094 2,088 173 165 43 83
Completely Rural 441 361 21 17 11 *
120405
Table 1.72B (REVISED) – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Percentages, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 16.5 16.2 1.6 1.4 0.7 0.6
GEOGRAPHIC DIVISION            
Northeast 16.4 17.6 1.8 1.7 0.8 0.7
New England 20.2 22.7 1.4 2.1 0.7 1.0
Middle Atlantic 15.1 15.7 2.0 1.6 0.9 0.6
Midwest 14.9 14.4 1.5a 1.1 0.6 0.4
East North Central 15.2 14.2 1.7a 1.1 0.7 0.4
West North Central 14.4 14.9 1.1 1.0 0.5 0.3
South 15.1a 13.4 1.6 1.4 0.6 0.7
South Atlantic 16.9b 13.2 1.7 1.6 0.6 0.8
East South Central 12.4 12.1 1.3 0.7 0.3 0.3
West South Central 13.4 14.5 1.5 1.3 0.8 0.7
West 20.2 21.2 1.7 1.7 0.6 0.4
Mountain 20.6 19.6 1.5 1.9 0.4 0.6
Pacific 20.1 21.9 1.8 1.6 0.7 0.3
COUNTY TYPE            
Large Metro 17.5 16.7 1.8 1.5 0.8 0.6
Small Metro 16.1 16.6 1.6 1.6 0.6 0.7
250K - 1 Mil. Pop. 16.7 16.7 1.6 1.8 0.7 0.9
< 250K Pop. 14.9 16.3 1.5 1.2 0.4 0.3
Nonmetro 13.9 13.9 1.2 1.0 0.4 0.3
Urbanized 14.7 14.7 1.4 1.0 0.5 0.1
Less Urbanized 13.4 14.1 1.1 1.1 0.3 0.6
Completely Rural 13.4 10.4 0.6 0.5 0.3 *
120405
Table 1.73A (REVISED) – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Numbers in Thousands, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 36,443 36,337 4,977 4,564 1,767 1,572
GEOGRAPHIC DIVISION            
Northeast 6,731 7,297 1,028 1,090 439 401
New England 2,149 2,458 238 344 87 155
Middle Atlantic 4,582 4,839 790 746 352 246
Midwest 7,379 7,109 1,039a 780 354 249
East North Central 5,191 4,901 775a 567 268 195
West North Central 2,187 2,208 264 213 86 54
South 12,098 11,212 1,636 1,517 579 616
South Atlantic 7,079b 5,809 902 891 312 374
East South Central 1,643 1,622 226a 138 55 49
West South Central 3,377 3,781 508 488 212 194
West 10,235 10,718 1,274 1,177 394 306
Mountain 3,278 3,159 378 402 103 136
Pacific 6,957 7,559 896 775 291 170
COUNTY TYPE            
Large Metro 20,278 19,717 2,827 2,489 1,075 863
Small Metro 10,968 11,372 1,535 1,522 513 562
250K - 1 Mil. Pop. 7,509 7,591 1,007 1,077 384 455
< 250K Pop. 3,459 3,781 529 444 129 107
Nonmetro 5,197 5,248 614 553 179 147
Urbanized 2,270 2,412 290 263 92a 38
Less Urbanized 2,443 2,433 292 261 74 107
Completely Rural 485 403 32 29 13 3
120405
Table 1.73B (REVISED) – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Percentages, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 16.2 16.0 2.2 2.0 0.8 0.7
GEOGRAPHIC DIVISION            
Northeast 16.1 17.3 2.5 2.6 1.1 1.0
New England 19.7 22.2 2.2 3.1 0.8 1.4
Middle Atlantic 14.9 15.6 2.6 2.4 1.1 0.8
Midwest 14.9 14.3 2.1a 1.6 0.7 0.5
East North Central 15.0 14.1 2.2a 1.6 0.8 0.6
West North Central 14.6 14.6 1.8 1.4 0.6 0.4
South 14.8 13.5 2.0 1.8 0.7 0.7
South Atlantic 16.3b 13.2 2.1 2.0 0.7 0.8
East South Central 12.3 12.0 1.7a 1.0 0.4 0.4
West South Central 13.5 14.8 2.0 1.9 0.8 0.8
West 19.7 20.5 2.5 2.2 0.8 0.6
Mountain 20.8 19.7 2.4 2.5 0.7 0.8
Pacific 19.3 20.8 2.5 2.1 0.8 0.5
COUNTY TYPE            
Large Metro 16.9 16.3 2.4 2.1 0.9 0.7
Small Metro 16.1 16.5 2.3 2.2 0.8 0.8
250K - 1 Mil. Pop. 16.6 16.7 2.2 2.4 0.9 1.0
< 250K Pop. 15.1 16.1 2.3 1.9 0.6 0.5
Nonmetro 14.0 14.1 1.7 1.5 0.5 0.4
Urbanized 14.8 14.8 1.9 1.6 0.6a 0.2
Less Urbanized 13.5 14.1 1.6 1.5 0.4 0.6
Completely Rural 13.3 10.6 0.9 0.8 0.4 0.1
120405
Table 1.74A (REVISED) – Crack Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 8,454 8,390 1,113 1,008 363 497
GEOGRAPHIC DIVISION            
Northeast 1,330 1,248 255 247 98 145
New England 332 372 62 79 34 62
Middle Atlantic 998 877 193 167 64 83
Midwest 1,700 1,792 275 183 74 74
East North Central 1,086 1,142 198 128 60 57
West North Central 614 650 77 55 14 17
South 3,089 2,865 374 408 142 206
South Atlantic 1,703 1,481 201 239 73 150
East South Central 656 486 47 57 11 6
West South Central 730 898 126 111 58 50
West 2,335 2,485 209 169 49 72
Mountain 627 771 58 80 8 40
Pacific 1,708 1,714 151 89 41 32
COUNTY TYPE            
Large Metro 4,333 4,098 588 495 186 226
Small Metro 2,593 2,750 388 342 145 221
250K - 1 Mil. Pop. 1,779 1,772 256 258 114 179
< 250K Pop. 813 978 132 84 31 42
Nonmetro 1,528 1,543 137 171 31 50
Urbanized 593 729 56 63 7 12
Less Urbanized 748 680 58 103 19 37
Completely Rural 187 133 22 4 5 *
120405
Table 1.74B (REVISED) – Crack Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 3.4 3.3 0.4 0.4 0.1 0.2
GEOGRAPHIC DIVISION            
Northeast 2.9 2.7 0.6 0.5 0.2 0.3
New England 2.8 3.1 0.5 0.7 0.3 0.5
Middle Atlantic 2.9 2.6 0.6 0.5 0.2 0.2
Midwest 3.1 3.2 0.5 0.3 0.1 0.1
East North Central 2.8 3.0 0.5 0.3 0.2 0.1
West North Central 3.7 3.9 0.5 0.3 0.1 0.1
South 3.4 3.1 0.4 0.4 0.2 0.2
South Atlantic 3.5 3.0 0.4 0.5 0.2 0.3
East South Central 4.4 3.2 0.3 0.4 0.1 0.0
West South Central 2.6 3.2 0.4 0.4 0.2 0.2
West 4.0 4.3 0.4 0.3 0.1 0.1
Mountain 3.6 4.3 0.3 0.4 0.0 0.2
Pacific 4.2 4.2 0.4 0.2 0.1 0.1
COUNTY TYPE            
Large Metro 3.3 3.1 0.4 0.4 0.1 0.2
Small Metro 3.4 3.6 0.5 0.4 0.2 0.3
250K - 1 Mil. Pop. 3.6 3.5 0.5 0.5 0.2 0.4
< 250K Pop. 3.2 3.7 0.5 0.3 0.1 0.2
Nonmetro 3.7 3.7 0.3 0.4 0.1 0.1
Urbanized 3.5 4.0 0.3 0.4 0.0 0.1
Less Urbanized 3.7 3.6 0.3 0.5 0.1 0.2
Completely Rural 4.6 3.2 0.6 0.1 0.1 *
120405
Table 1.75A (REVISED) – Hallucinogen Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 36,064 37,404 3,670b 4,536 1,059 1,263
GEOGRAPHIC DIVISION            
Northeast 6,743 7,297 601b 938 173a 287
New England 2,088a 2,534 186b 338 36b 115
Middle Atlantic 4,655 4,763 415a 601 137 172
Midwest 7,632 7,692 777 782 203 208
East North Central 5,485 5,233 505 549 120 148
West North Central 2,147 2,459 272 233 83 60
South 11,237 11,208 1,138 1,341 305 347
South Atlantic 6,474 5,930 575 630 153 155
East South Central 1,585 1,678 192 188 62 52
West South Central 3,177 3,600 372a 523 90 140
West 10,453 11,206 1,154b 1,475 378 421
Mountain 3,338 3,546 389 488 113 145
Pacific 7,115 7,661 765a 986 265 276
COUNTY TYPE            
Large Metro 19,753 20,284 2,013b 2,528 607 739
Small Metro 11,281 11,974 1,185b 1,456 336 393
250K - 1 Mil. Pop. 7,497 8,018 771 904 233 227
< 250K Pop. 3,784 3,956 413a 553 103 166
Nonmetro 5,030 5,145 473 552 115 131
Urbanized 2,320 2,579 245 303 51 46
Less Urbanized 2,244 2,163 206 216 58 79
Completely Rural 466 403 21 33 7 6
120405
Table 1.75B (REVISED) – Hallucinogen Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 14.4 14.9 1.5b 1.8 0.4 0.5
GEOGRAPHIC DIVISION            
Northeast 14.6 15.7 1.3b 2.0 0.4a 0.6
New England 17.3a 20.8 1.5b 2.8 0.3b 0.9
Middle Atlantic 13.7 13.9 1.2a 1.8 0.4 0.5
Midwest 13.9 13.9 1.4 1.4 0.4 0.4
East North Central 14.3 13.6 1.3 1.4 0.3 0.4
West North Central 13.0 14.7 1.6 1.4 0.5 0.4
South 12.4 12.2 1.3 1.5 0.3 0.4
South Atlantic 13.5 12.2 1.2 1.3 0.3 0.3
East South Central 10.7 11.2 1.3 1.3 0.4 0.3
West South Central 11.3 12.6 1.3a 1.8 0.3 0.5
West 18.1 19.3 2.0b 2.5 0.7 0.7
Mountain 19.0 19.9 2.2 2.7 0.6 0.8
Pacific 17.7 19.0 1.9a 2.4 0.7 0.7
COUNTY TYPE            
Large Metro 14.8 15.2 1.5b 1.9 0.5 0.6
Small Metro 14.9 15.6 1.6b 1.9 0.4 0.5
250K - 1 Mil. Pop. 15.0 15.8 1.5 1.8 0.5 0.4
< 250K Pop. 14.9 15.2 1.6a 2.1 0.4 0.6
Nonmetro 12.2 12.5 1.1 1.3 0.3 0.3
Urbanized 13.5 14.3 1.4 1.7 0.3 0.3
Less Urbanized 11.2 11.4 1.0 1.1 0.3 0.4
Completely Rural 11.6 9.6 0.5 0.8 0.2 0.1
120405
Table 1.76A (REVISED) – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 22,430 22,552 2,065 2,109 644 562
GEOGRAPHIC DIVISION            
Northeast 4,238 4,464 352 374 78 84
New England 1,146 1,312 83 116 29 43
Middle Atlantic 3,092 3,153 269 258 49 40
Midwest 5,155 4,749 377 367 103 100
East North Central 3,626 3,321 264 271 78 73
West North Central 1,529 1,428 113 96 25 26
South 7,238 6,947 612 620 180 116
South Atlantic 4,302 3,923 290 331 81 73
East South Central 994 1,076 79 127 25 17
West South Central 1,942 1,948 242a 162 73a 25
West 5,799 6,392 724 749 284 263
Mountain 1,783 1,911 153 119 56 36
Pacific 4,016 4,481 571 630 228 227
COUNTY TYPE            
Large Metro 12,382 12,557 1,183 1,221 348 350
Small Metro 6,703 6,595 562 595 201 145
250K - 1 Mil. Pop. 4,659 4,519 380 384 158 101
< 250K Pop. 2,044 2,076 182 211 43 44
Nonmetro 3,345 3,400 319 293 96 67
Urbanized 1,561 1,637 164 128 47 32
Less Urbanized 1,517 1,414 134 142 43 28
Completely Rural 267 349 21 23 6 7
120405
Table 1.76B (REVISED) – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 9.0 9.0 0.8 0.8 0.3 0.2
GEOGRAPHIC DIVISION            
Northeast 9.2 9.6 0.8 0.8 0.2 0.2
New England 9.5 10.8 0.7 0.9 0.2 0.4
Middle Atlantic 9.1 9.2 0.8 0.8 0.1 0.1
Midwest 9.4 8.6 0.7 0.7 0.2 0.2
East North Central 9.4 8.6 0.7 0.7 0.2 0.2
West North Central 9.2 8.5 0.7 0.6 0.2 0.2
South 8.0 7.5 0.7 0.7 0.2 0.1
South Atlantic 9.0 8.1 0.6 0.7 0.2 0.2
East South Central 6.7 7.2 0.5 0.8 0.2 0.1
West South Central 6.9 6.8 0.9a 0.6 0.3a 0.1
West 10.0 11.0 1.3 1.3 0.5 0.5
Mountain 10.1 10.7 0.9 0.7 0.3 0.2
Pacific 10.0 11.1 1.4 1.6 0.6 0.6
COUNTY TYPE            
Large Metro 9.3 9.4 0.9 0.9 0.3 0.3
Small Metro 8.9 8.6 0.7 0.8 0.3 0.2
250K - 1 Mil. Pop. 9.3 8.9 0.8 0.8 0.3 0.2
< 250K Pop. 8.0 8.0 0.7 0.8 0.2 0.2
Nonmetro 8.1 8.2 0.8 0.7 0.2 0.2
Urbanized 9.1 9.1 1.0 0.7 0.3 0.2
Less Urbanized 7.6 7.4 0.7 0.7 0.2 0.1
Completely Rural 6.6 8.3 0.5 0.6 0.1 0.2
120405
Table 1.77A (REVISED) – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Numbers in Thousands, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 2,326 2,283 986 960 270 244
GEOGRAPHIC DIVISION            
Northeast 355 323 151 132 37 31
New England 98 75 44 35 14 12
Middle Atlantic 257 247 107 97 22 19
Midwest 484 486 208 211 56 62
East North Central 337 348 141 157 38 49
West North Central 147 138 67 54 18 13
South 813 827 308 345 74 68
South Atlantic 464 432 149 172 31 39
East South Central 121 150 47a 75 12 14
West South Central 227 245 111 98 30 14
West 674 646 319 272 104 83
Mountain 236a 171 91 69 30 17
Pacific 438 475 228 203 74 66
COUNTY TYPE            
Large Metro 1,177 1,200 519 488 146 124
Small Metro 706 718 274 316 85 83
250K - 1 Mil. Pop. 460 455 185 208 67 58
< 250K Pop. 247 263 90 108 19 25
Nonmetro 442a 365 192 155 39 37
Urbanized 195 159 91 73 16 16
Less Urbanized 204 165 85 65 17 15
Completely Rural 43 42 16 17 6 7
120405
Table 1.77B (REVISED) – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Percentages, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 9.3 9.3 4.0 3.9 1.1 1.0
GEOGRAPHIC DIVISION            
Northeast 8.1 7.5 3.5 3.1 0.8 0.7
New England 8.7 6.8 3.9 3.1 1.3 1.0
Middle Atlantic 7.9 7.8 3.3 3.0 0.7 0.6
Midwest 8.8 9.0 3.8 3.9 1.0 1.2
East North Central 8.7 9.2 3.6 4.2 1.0 1.3
West North Central 8.9 8.5 4.1 3.3 1.1 0.8
South 9.0 9.2 3.4 3.8 0.8 0.8
South Atlantic 10.1 9.5 3.3 3.8 0.7 0.9
East South Central 8.3 10.3 3.2a 5.2 0.8 1.0
West South Central 7.6 8.1 3.7 3.3 1.0 0.5
West 11.3 11.0 5.4 4.6 1.7 1.4
Mountain 13.1a 9.5 5.1 3.8 1.7 0.9
Pacific 10.6 11.6 5.5 5.0 1.8 1.6
COUNTY TYPE            
Large Metro 8.8 9.2 3.9 3.7 1.1 1.0
Small Metro 9.5 9.4 3.7 4.1 1.2 1.1
250K - 1 Mil. Pop. 9.4 8.9 3.8 4.1 1.4 1.1
< 250K Pop. 9.8 10.3 3.6 4.2 0.7 1.0
Nonmetro 10.6 9.4 4.6 4.0 0.9 1.0
Urbanized 10.9 9.3 5.1 4.3 0.9 0.9
Less Urbanized 10.1 9.2 4.2 3.6 0.9 0.8
Completely Rural 11.5 10.7 4.3 4.5 1.5 1.7
120405
Table 1.78A (REVISED) – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 52,154 51,991 15,190 16,064 6,210a 6,980
GEOGRAPHIC DIVISION            
Northeast 8,806 8,553 2,427 2,646 1,037 1,124
New England 2,418 2,357 723 774 382 303
Middle Atlantic 6,387 6,196 1,705 1,873 655 821
Midwest 11,179 10,639 3,353 3,289 1,402 1,368
East North Central 7,866 7,433 2,462 2,474 1,057 1,058
West North Central 3,313 3,206 891 815 345 311
South 18,123 18,725 5,361 5,960 2,203a 2,675
South Atlantic 9,753 9,878 2,692 2,996 1,104 1,334
East South Central 2,890 2,991 967 948 463 495
West South Central 5,480 5,856 1,703 2,016 635a 847
West 14,047 14,075 4,048 4,169 1,568 1,812
Mountain 4,288 4,362 1,248 1,389 437a 635
Pacific 9,759 9,713 2,801 2,781 1,131 1,177
COUNTY TYPE            
Large Metro 27,857 27,343 7,999 8,297 3,233 3,590
Small Metro 16,242 16,609 4,804 5,235 1,998 2,187
250K - 1 Mil. Pop. 10,943 11,176 3,148 3,504 1,399 1,336
< 250K Pop. 5,299 5,433 1,657 1,731 599a 851
Nonmetro 8,055 8,039 2,386 2,532 978 1,202
Urbanized 3,494 3,791 1,019a 1,289 437 575
Less Urbanized 3,845 3,602 1,223 1,060 484 543
Completely Rural 716 646 144 183 57 83
120405
Table 1.78B (REVISED) – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 20.9 20.6 6.1 6.4 2.5a 2.8
GEOGRAPHIC DIVISION            
Northeast 19.1 18.4 5.3 5.7 2.2 2.4
New England 20.1 19.3 6.0 6.4 3.2 2.5
Middle Atlantic 18.8 18.1 5.0 5.5 1.9 2.4
Midwest 20.3 19.3 6.1 6.0 2.6 2.5
East North Central 20.5 19.3 6.4 6.4 2.8 2.7
West North Central 20.0 19.2 5.4 4.9 2.1 1.9
South 19.9 20.3 5.9 6.5 2.4a 2.9
South Atlantic 20.3 20.3 5.6 6.2 2.3 2.7
East South Central 19.4 20.0 6.5 6.3 3.1 3.3
West South Central 19.5 20.6 6.1 7.1 2.3a 3.0
West 24.3 24.2 7.0 7.2 2.7 3.1
Mountain 24.4 24.5 7.1 7.8 2.5a 3.6
Pacific 24.3 24.0 7.0 6.9 2.8 2.9
COUNTY TYPE            
Large Metro 20.9 20.4 6.0 6.2 2.4 2.7
Small Metro 21.5 21.6 6.4 6.8 2.6 2.9
250K - 1 Mil. Pop. 21.9 22.1 6.3 6.9 2.8 2.6
< 250K Pop. 20.8 20.8 6.5 6.6 2.4a 3.3
Nonmetro 19.5 19.5 5.8 6.1 2.4 2.9
Urbanized 20.4 21.0 5.9 7.1 2.5 3.2
Less Urbanized 19.2 18.9 6.1 5.6 2.4 2.9
Completely Rural 17.8 15.4 3.6 4.4 1.4 2.0
120405
Table 1.79A (REVISED) – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Numbers in Thousands, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 2,783 2,810 1,919 1,895 711 774
GEOGRAPHIC DIVISION            
Northeast 355 383 259 266 112 106
New England 90 106 63 76 19 35
Middle Atlantic 265 277 196 190 93 71
Midwest 635 612 445 434 175 189
East North Central 450 453 317 327 134 143
West North Central 185 158 128 107 41 46
South 1,066 1,085 677 717 253 296
South Atlantic 553 514 340 351 133 123
East South Central 160b 220 100b 153 40b 76
West South Central 353 351 237 212 80 96
West 727 731 538 479 170 183
Mountain 234 198 179 140 72 50
Pacific 493 533 358 339 98 133
COUNTY TYPE            
Large Metro 1,362 1,422 966 931 358 377
Small Metro 888 943 601 665 215 263
250K - 1 Mil. Pop. 575 571 394 393 131 153
< 250K Pop. 313 373 208 271 84 110
Nonmetro 533a 445 351 299 138 134
Urbanized 224 217 159 157 60 65
Less Urbanized 266a 197 168a 124 68 59
Completely Rural 44 30 24 18 10 9
120405
Table 1.79B (REVISED) – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Percentages, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 11.2 11.4 7.7 7.7 2.9 3.1
GEOGRAPHIC DIVISION            
Northeast 8.1 8.9 5.9 6.2 2.6 2.5
New England 8.0 9.6 5.6 6.9 1.7 3.2
Middle Atlantic 8.2 8.7 6.0 6.0 2.9 2.2
Midwest 11.5 11.3 8.1 8.0 3.2 3.5
East North Central 11.6 12.0 8.2 8.6 3.5 3.8
West North Central 11.3 9.8 7.8 6.6 2.5 2.8
South 11.8 12.0 7.5 8.0 2.8 3.3
South Atlantic 12.1 11.3 7.4 7.7 2.9 2.7
East South Central 10.9b 15.1 6.8b 10.5 2.7b 5.2
West South Central 11.7 11.6 7.9 7.1 2.6 3.2
West 12.2 12.4 9.0 8.1 2.8 3.1
Mountain 13.0 11.0 9.9 7.7 4.0 2.8
Pacific 11.9 13.1 8.6 8.3 2.4 3.3
COUNTY TYPE            
Large Metro 10.2 10.9 7.3 7.1 2.7 2.9
Small Metro 12.0 12.3 8.1 8.7 2.9 3.4
250K - 1 Mil. Pop. 11.7 11.2 8.0 7.7 2.7 3.0
< 250K Pop. 12.5 14.6 8.3a 10.6 3.3 4.3
Nonmetro 12.8 11.4 8.4 7.7 3.3 3.4
Urbanized 12.5 12.7 8.9 9.1 3.4 3.8
Less Urbanized 13.2 11.0 8.4 6.9 3.3 3.3
Completely Rural 11.7 7.8 6.4 4.7 2.7 2.3
120405
Table 1.80A (REVISED) – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Numbers in Thousands, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 9,694 9,896 4,891 5,061 1,936 2,133
GEOGRAPHIC DIVISION            
Northeast 1,737 1,746 870 992 356 434
New England 472 523 241a 306 92b 147
Middle Atlantic 1,265 1,223 628 687 264 287
Midwest 2,155 2,198 1,067 1,090 416 450
East North Central 1,473 1,565 753 803 312 342
West North Central 682 634 314 287 105 107
South 3,341 3,512 1,741 1,806 731 759
South Atlantic 1,547 1,681 801 884 324 346
East South Central 558 630 308 310 145 136
West South Central 1,235 1,201 633 613 263 277
West 2,461 2,440 1,214 1,172 432 490
Mountain 861 785 370 382 142 162
Pacific 1,600 1,655 843 791 290 328
COUNTY TYPE            
Large Metro 5,008 4,992 2,499 2,559 960 1,014
Small Metro 3,177 3,327 1,641 1,707 653 767
250K - 1 Mil. Pop. 2,049 2,085 1,027 1,090 421 497
< 250K Pop. 1,128 1,242 614 617 232 270
Nonmetro 1,509 1,577 751 795 323 351
Urbanized 692 779 319 400 141 178
Less Urbanized 731 704 385 353 161 157
Completely Rural 85 95 47 42 21 17
120405
Table 1.80B (REVISED) – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Percentages, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 29.4 29.5 14.9 15.1 5.9 6.4
GEOGRAPHIC DIVISION            
Northeast 29.0 28.5 14.5 16.2 5.9 7.1
New England 30.3 32.7 15.5 19.2 5.9b 9.2
Middle Atlantic 28.5 27.0 14.2 15.2 6.0 6.3
Midwest 29.6 30.0 14.7 14.9 5.7 6.1
East North Central 29.2 30.8 15.0 15.8 6.2 6.7
West North Central 30.4 28.0 14.0 12.7 4.7 4.7
South 28.4 29.2 14.8 15.0 6.2 6.3
South Atlantic 25.9 27.5 13.4 14.5 5.4 5.7
East South Central 29.8 33.1 16.4 16.3 7.7 7.1
West South Central 31.5 30.0 16.1 15.3 6.7 6.9
West 31.1 30.1 15.3 14.5 5.5 6.1
Mountain 36.3 32.4 15.6 15.8 6.0 6.7
Pacific 28.9 29.1 15.2 13.9 5.2 5.8
COUNTY TYPE            
Large Metro 28.1 28.0 14.0 14.3 5.4 5.7
Small Metro 31.5 31.7 16.2 16.3 6.5 7.3
250K - 1 Mil. Pop. 31.3 31.2 15.7 16.3 6.4 7.4
< 250K Pop. 31.7 32.7 17.3 16.2 6.5 7.1
Nonmetro 30.2 30.1 15.0 15.2 6.5 6.7
Urbanized 30.3 31.0 14.0 15.9 6.2 7.1
Less Urbanized 31.1 29.3 16.4 14.7 6.8 6.5
Completely Rural 24.0 29.1 13.1 12.8 6.0 5.1
120405
Table 1.81A (REVISED) – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Numbers in Thousands, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 39,677 39,285 8,380 9,108 3,563 4,072
GEOGRAPHIC DIVISION            
Northeast 6,713 6,424 1,299 1,387 569 584
New England 1,856 1,727 418 391 270a 120
Middle Atlantic 4,857 4,697 881 996 299 463
Midwest 8,389 7,829 1,840 1,765 810 730
East North Central 5,943 5,415 1,392 1,344 612 572
West North Central 2,446 2,414 449 421 198 158
South 13,715 14,128 2,943 3,437 1,218a 1,621
South Atlantic 7,652 7,683 1,551 1,761 647 864
East South Central 2,171 2,141 559 485 278 283
West South Central 3,892 4,304 833a 1,191 293a 473
West 10,858 10,904 2,297 2,519 966 1,139
Mountain 3,192 3,379 698 867 223b 423
Pacific 7,666 7,525 1,599 1,651 743 716
COUNTY TYPE            
Large Metro 21,486 20,929 4,534 4,807 1,916 2,198
Small Metro 12,178 12,339 2,562 2,863 1,130 1,157
250K - 1 Mil. Pop. 8,319 8,520 1,727 2,021 847 685
< 250K Pop. 3,858 3,818 835 843 283a 472
Nonmetro 6,013 6,017 1,284 1,438 518 717
Urbanized 2,578 2,796 541 732 236 332
Less Urbanized 2,848 2,701 670 583 256 327
Completely Rural 587 521 73 123 25 58
120405
Table 1.81B (REVISED) – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Percentages, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 20.7 20.3 4.4 4.7 1.9 2.1
GEOGRAPHIC DIVISION            
Northeast 18.8 17.9 3.6 3.9 1.6 1.6
New England 19.8 18.2 4.5 4.1 2.9a 1.3
Middle Atlantic 18.4 17.7 3.3 3.8 1.1 1.7
Midwest 19.9 18.5 4.4 4.2 1.9 1.7
East North Central 20.2 18.3 4.7 4.5 2.1 1.9
West North Central 19.3 18.8 3.5 3.3 1.6 1.2
South 19.6 19.9 4.2 4.8 1.7 2.3
South Atlantic 20.4 20.3 4.1 4.6 1.7 2.3
East South Central 18.8 18.4 4.9 4.2 2.4 2.4
West South Central 18.4 20.0 3.9a 5.5 1.4 2.2
West 24.7 24.7 5.2 5.7 2.2 2.6
Mountain 23.8 24.9 5.2 6.4 1.7b 3.1
Pacific 25.1 24.6 5.2 5.4 2.4 2.3
COUNTY TYPE            
Large Metro 21.1 20.3 4.4 4.7 1.9 2.1
Small Metro 21.0 21.1 4.4 4.9 1.9 2.0
250K - 1 Mil. Pop. 21.6 21.9 4.5 5.2 2.2 1.8
< 250K Pop. 19.9 19.3 4.3 4.3 1.5a 2.4
Nonmetro 18.7 18.7 4.0 4.5 1.6 2.2
Urbanized 19.7 20.2 4.1 5.3 1.8 2.4
Less Urbanized 18.2 18.2 4.3 3.9 1.6 2.2
Completely Rural 17.8 15.0 2.2 3.5 0.8 1.7
120405
Table 1.82A (REVISED) – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Numbers in Thousands, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 49,371 49,181 13,271 14,169 5,499a 6,205
GEOGRAPHIC DIVISION            
Northeast 8,450 8,170 2,169 2,380 925 1,017
New England 2,328 2,250 660 697 362 267
Middle Atlantic 6,122 5,920 1,509 1,683 562 750
Midwest 10,544 10,028 2,907 2,855 1,227 1,179
East North Central 7,416 6,979 2,145 2,147 923 914
West North Central 3,128 3,048 762 708 303 265
South 17,056 17,640 4,684 5,243 1,950a 2,379
South Atlantic 9,200 9,364 2,351 2,645 971 1,210
East South Central 2,729 2,771 867 795 423 419
West South Central 5,127 5,505 1,466a 1,804 556a 750
West 13,320 13,344 3,511 3,691 1,398 1,629
Mountain 4,053 4,164 1,068 1,249 365b 584
Pacific 9,267 9,180 2,442 2,442 1,033 1,044
COUNTY TYPE            
Large Metro 26,495 25,921 7,033 7,366 2,875 3,213
Small Metro 15,355 15,666 4,203 4,570 1,783 1,924
250K - 1 Mil. Pop. 10,369 10,605 2,754 3,111 1,268 1,183
< 250K Pop. 4,986 5,061 1,449 1,459 515a 742
Nonmetro 7,522 7,594 2,035 2,233 840 1,068
Urbanized 3,270 3,574 860a 1,132 377 510
Less Urbanized 3,579 3,405 1,055 935 417 484
Completely Rural 672 615 120 165 47 74
120405
Table 1.82B (REVISED) – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Percentages, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 22.0 21.6 5.9 6.2 2.4 2.7
GEOGRAPHIC DIVISION            
Northeast 20.3 19.4 5.2 5.7 2.2 2.4
New England 21.3 20.3 6.0 6.3 3.3 2.4
Middle Atlantic 19.9 19.1 4.9 5.4 1.8 2.4
Midwest 21.3 20.2 5.9 5.7 2.5 2.4
East North Central 21.5 20.1 6.2 6.2 2.7 2.6
West North Central 20.9 20.2 5.1 4.7 2.0 1.8
South 20.8 21.2 5.7 6.3 2.4 2.9
South Atlantic 21.2 21.3 5.4 6.0 2.2 2.7
East South Central 20.4 20.5 6.5 5.9 3.2 3.1
West South Central 20.4 21.6 5.8 7.1 2.2 2.9
West 25.7 25.5 6.8 7.1 2.7 3.1
Mountain 25.7 26.0 6.8 7.8 2.3b 3.6
Pacific 25.7 25.3 6.8 6.7 2.9 2.9
COUNTY TYPE            
Large Metro 22.1 21.5 5.9 6.1 2.4 2.7
Small Metro 22.6 22.7 6.2 6.6 2.6 2.8
250K - 1 Mil. Pop. 23.0 23.3 6.1 6.8 2.8 2.6
< 250K Pop. 21.7 21.5 6.3 6.2 2.2a 3.1
Nonmetro 20.3 20.3 5.5 6.0 2.3 2.9
Urbanized 21.3 21.9 5.6 6.9 2.5 3.1
Less Urbanized 19.8 19.8 5.8 5.4 2.3 2.8
Completely Rural 18.4 16.2 3.3 4.3 1.3 2.0
120405
Table 1.83A (REVISED) – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 34,992 35,197 11,916 12,450 4,732 5,282
GEOGRAPHIC DIVISION            
Northeast 5,914 5,851 1,899 2,088 792 893
New England 1,777 1,637 600 594 310 229
Middle Atlantic 4,137 4,215 1,299 1,494 482 663
Midwest 7,494 7,442 2,691 2,534 1,088 1,002
East North Central 5,602 5,370 2,020 1,918 840 779
West North Central 1,892 2,072 671 617 248 223
South 12,165 12,635 4,107a 4,699 1,601b 2,069
South Atlantic 6,208 6,548 1,975 2,346 776 1,044
East South Central 2,040 2,096 832 706 392 351
West South Central 3,917 3,992 1,300a 1,647 433b 674
West 9,419 9,268 3,219 3,129 1,251 1,319
Mountain 2,930 2,971 975 1,115 332a 482
Pacific 6,490 6,297 2,244 2,014 919 837
COUNTY TYPE            
Large Metro 18,716 18,441 6,284 6,358 2,462 2,641
Small Metro 10,815 11,256 3,818 4,123 1,517 1,736
250K - 1 Mil. Pop. 7,094 7,533 2,422 2,737 1,001 1,051
< 250K Pop. 3,721 3,723 1,396 1,386 517 685
Nonmetro 5,461 5,499 1,814 1,969 752 905
Urbanized 2,455 2,703 771a 1,017 321 446
Less Urbanized 2,609 2,401 920 852 383 401
Completely Rural 398 396 123 101 47 59
120405
Table 1.83B (REVISED) – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 14.0 14.0 4.8 4.9 1.9 2.1
GEOGRAPHIC DIVISION            
Northeast 12.8 12.6 4.1 4.5 1.7 1.9
New England 14.7 13.4 5.0 4.9 2.6 1.9
Middle Atlantic 12.2 12.3 3.8 4.4 1.4 1.9
Midwest 13.6 13.5 4.9 4.6 2.0 1.8
East North Central 14.6 14.0 5.3 5.0 2.2 2.0
West North Central 11.4 12.4 4.0 3.7 1.5 1.3
South 13.4 13.7 4.5 5.1 1.8a 2.2
South Atlantic 12.9 13.5 4.1 4.8 1.6 2.1
East South Central 13.7 14.0 5.6 4.7 2.6 2.3
West South Central 13.9 14.0 4.6a 5.8 1.5b 2.4
West 16.3 15.9 5.6 5.4 2.2 2.3
Mountain 16.7 16.7 5.5 6.3 1.9 2.7
Pacific 16.1 15.6 5.6 5.0 2.3 2.1
COUNTY TYPE            
Large Metro 14.1 13.8 4.7 4.8 1.8 2.0
Small Metro 14.3 14.7 5.1 5.4 2.0 2.3
250K - 1 Mil. Pop. 14.2 14.9 4.8 5.4 2.0 2.1
< 250K Pop. 14.6 14.3 5.5 5.3 2.0 2.6
Nonmetro 13.2 13.3 4.4 4.8 1.8 2.2
Urbanized 14.3 15.0 4.5a 5.6 1.9 2.5
Less Urbanized 13.0 12.6 4.6 4.5 1.9 2.1
Completely Rural 9.9 9.5 3.0 2.4 1.2 1.4
120405
Table 1.84A (REVISED) – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Numbers in Thousands, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 2,353 2,393 1,613 1,628 566a 658
GEOGRAPHIC DIVISION            
Northeast 293 309 213 220 94 83
New England 69 81 50 62 14a 29
Middle Atlantic 224 229 163 158 80 55
Midwest 550 530 382 374 140 155
East North Central 396 392 274 281 103 119
West North Central 154 138 108 93 37 36
South 877 930 544 615 194a 250
South Atlantic 457 448 284 302 95 99
East South Central 138a 186 86a 129 34b 68
West South Central 281 296 174 183 65 83
West 634 623 474 419 139 169
Mountain 202 168 163a 112 53 45
Pacific 432 455 310 307 86 124
COUNTY TYPE            
Large Metro 1,127 1,199 795 793 280 321
Small Metro 753 800 511 574 178 227
250K - 1 Mil. Pop. 481 489 327 350 111 135
< 250K Pop. 272 311 183 224 68 92
Nonmetro 474a 394 307 261 108 109
Urbanized 190 189 135 141 41 53
Less Urbanized 242a 179 152b 104 60 48
Completely Rural 42 27 20 16 7 8
120405
Table 1.84B (REVISED) – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Percentages, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 9.5 9.7 6.5 6.6 2.3a 2.7
GEOGRAPHIC DIVISION            
Northeast 6.7 7.2 4.9 5.1 2.1 1.9
New England 6.1 7.3 4.4 5.5 1.2a 2.6
Middle Atlantic 6.9 7.2 5.0 5.0 2.5 1.7
Midwest 10.0 9.8 6.9 6.9 2.5 2.9
East North Central 10.2 10.3 7.1 7.4 2.7 3.1
West North Central 9.3 8.5 6.6 5.8 2.2 2.2
South 9.7 10.3 6.0 6.8 2.1a 2.8
South Atlantic 10.0 9.9 6.2 6.7 2.1 2.2
East South Central 9.4a 12.8 5.9b 8.9 2.3b 4.7
West South Central 9.4 9.8 5.8 6.1 2.2 2.7
West 10.6 10.6 8.0 7.1 2.3 2.9
Mountain 11.2 9.3 9.0a 6.2 2.9 2.5
Pacific 10.4 11.2 7.5 7.5 2.1 3.0
COUNTY TYPE            
Large Metro 8.5 9.2 6.0 6.1 2.1 2.5
Small Metro 10.2 10.4 6.9 7.5 2.4 3.0
250K - 1 Mil. Pop. 9.8 9.5 6.7 6.8 2.3 2.6
< 250K Pop. 10.8 12.2 7.3 8.7 2.7 3.6
Nonmetro 11.3 10.1 7.4 6.7 2.6 2.8
Urbanized 10.6 11.0 7.6 8.2 2.3 3.1
Less Urbanized 12.0 9.9 7.5 5.8 3.0 2.7
Completely Rural 11.0 6.9 5.4 4.2 1.8 2.1
120405
Table 1.85A (REVISED) – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Numbers in Thousands, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 8,096 8,221 3,956 4,027 1,489 1,610
GEOGRAPHIC DIVISION            
Northeast 1,418 1,468 686 800 262a 337
New England 384 420 196 239 68a 105
Middle Atlantic 1,034 1,048 491 561 194 232
Midwest 1,858 1,857 900 856 333 337
East North Central 1,299 1,325 641 634 254 256
West North Central 559 532 259 222 80 81
South 2,777 2,882 1,400 1,482 555 581
South Atlantic 1,303 1,331 649 707 244 260
East South Central 465 542 261 251 118 112
West South Central 1,009 1,009 490 524 193 209
West 2,043 2,014 970 889 339 355
Mountain 712 662 314 322 118 132
Pacific 1,331 1,352 655 567 221 223
COUNTY TYPE            
Large Metro 4,170 4,094 1,989 2,023 729 747
Small Metro 2,681 2,791 1,344 1,355 509 587
250K - 1 Mil. Pop. 1,713 1,735 842 859 313 372
< 250K Pop. 967 1,057 502 496 196 214
Nonmetro 1,246 1,336 623 650 251 277
Urbanized 575 667 272 330 103 136
Less Urbanized 598 587 311 285 128 125
Completely Rural 73 82 40 35 20 16
120405
Table 1.85B (REVISED) – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Percentages, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 24.6 24.5 12.0 12.0 4.5 4.8
GEOGRAPHIC DIVISION            
Northeast 23.7 24.0 11.5 13.1 4.4 5.5
New England 24.7 26.3 12.6 15.0 4.4a 6.6
Middle Atlantic 23.3 23.2 11.1 12.4 4.4 5.1
Midwest 25.5 25.3 12.4 11.7 4.6 4.6
East North Central 25.8 26.1 12.7 12.5 5.0 5.0
West North Central 24.9 23.5 11.6 9.8 3.6 3.6
South 23.6 24.0 11.9 12.3 4.7 4.8
South Atlantic 21.8 21.8 10.9 11.6 4.1 4.3
East South Central 24.8 28.5 13.9 13.2 6.3 5.9
West South Central 25.7 25.2 12.5 13.1 4.9 5.2
West 25.8 24.9 12.3 11.0 4.3 4.4
Mountain 30.1 27.3 13.3 13.3 5.0 5.5
Pacific 24.0 23.8 11.8 10.0 4.0 3.9
COUNTY TYPE            
Large Metro 23.4 22.9 11.1 11.3 4.1 4.2
Small Metro 26.5 26.6 13.3 12.9 5.0 5.6
250K - 1 Mil. Pop. 26.2 25.9 12.9 12.8 4.8 5.6
< 250K Pop. 27.2 27.8 14.1 13.0 5.5 5.6
Nonmetro 25.0 25.5 12.5 12.4 5.0 5.3
Urbanized 25.2 26.5 11.9 13.1 4.5 5.4
Less Urbanized 25.4 24.4 13.2 11.9 5.5 5.2
Completely Rural 20.4 25.3 11.4 10.7 5.7 5.0
120405
Table 1.86A (REVISED) – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Numbers in Thousands, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 24,543 24,583 6,347 6,795 2,676 3,014
GEOGRAPHIC DIVISION            
Northeast 4,203 4,074 1,000 1,067 436 473
New England 1,323 1,136 354 293 229a 96
Middle Atlantic 2,879 2,938 645 774 208 377
Midwest 5,087 5,055 1,409 1,304 615 509
East North Central 3,907 3,653 1,105 1,002 484 403
West North Central 1,180 1,402 303 302 131 106
South 8,511 8,823 2,163 2,602 852a 1,238
South Atlantic 4,448 4,768 1,042 1,337 436 685
East South Central 1,436 1,368 485 325 240 171
West South Central 2,627 2,687 636a 939 175b 382
West 6,742 6,632 1,776 1,822 773 795
Mountain 2,015 2,141 497a 681 161a 304
Pacific 4,727 4,490 1,279 1,140 612 490
COUNTY TYPE            
Large Metro 13,419 13,148 3,500 3,542 1,453 1,573
Small Metro 7,381 7,665 1,963 2,194 830 922
250K - 1 Mil. Pop. 4,900 5,310 1,253 1,528 577 544
< 250K Pop. 2,481 2,355 711 666 253 378
Nonmetro 3,742 3,770 884 1,058 394 519
Urbanized 1,690 1,848 364a 546 178 257
Less Urbanized 1,768 1,635 458 463 195 228
Completely Rural 284 286 62 50 21 34
120405
Table 1.86B (REVISED) – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Percentages, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 12.8 12.7 3.3 3.5 1.4 1.6
GEOGRAPHIC DIVISION            
Northeast 11.8 11.3 2.8 3.0 1.2 1.3
New England 14.1 12.0 3.8 3.1 2.4a 1.0
Middle Atlantic 10.9 11.1 2.4 2.9 0.8 1.4
Midwest 12.1 11.9 3.3 3.1 1.5 1.2
East North Central 13.3 12.3 3.8 3.4 1.6 1.4
West North Central 9.3 10.9 2.4 2.4 1.0 0.8
South 12.1 12.4 3.1 3.7 1.2a 1.7
South Atlantic 11.9 12.6 2.8 3.5 1.2 1.8
East South Central 12.5 11.8 4.2 2.8 2.1 1.5
West South Central 12.4 12.5 3.0a 4.4 0.8b 1.8
West 15.3 15.0 4.0 4.1 1.8 1.8
Mountain 15.0 15.8 3.7a 5.0 1.2a 2.2
Pacific 15.5 14.7 4.2 3.7 2.0 1.6
COUNTY TYPE            
Large Metro 13.2 12.8 3.4 3.4 1.4 1.5
Small Metro 12.7 13.1 3.4 3.7 1.4 1.6
250K - 1 Mil. Pop. 12.7 13.7 3.2 3.9 1.5 1.4
< 250K Pop. 12.8 11.9 3.7 3.4 1.3 1.9
Nonmetro 11.7 11.7 2.8 3.3 1.2 1.6
Urbanized 12.9 13.4 2.8 4.0 1.4 1.9
Less Urbanized 11.3 11.0 2.9 3.1 1.2 1.5
Completely Rural 8.6 8.2 1.9 1.4 0.6 1.0
120405
Table 1.87A (REVISED) – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Numbers in Thousands, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 32,639 32,804 10,304 10,822 4,165 4,624
GEOGRAPHIC DIVISION            
Northeast 5,621 5,542 1,686 1,868 698 809
New England 1,708 1,556 550 532 297 201
Middle Atlantic 3,913 3,986 1,136 1,336 402a 609
Midwest 6,945 6,912 2,309 2,160 949 846
East North Central 5,206 4,978 1,746 1,637 737 660
West North Central 1,738 1,934 563 524 211 187
South 11,288 11,705 3,563 4,084 1,407a 1,819
South Atlantic 5,751 6,100 1,691 2,044 681 945
East South Central 1,902 1,910 746 577 358 282
West South Central 3,636 3,695 1,126a 1,463 368b 592
West 8,785 8,645 2,745 2,710 1,112 1,149
Mountain 2,727 2,803 812a 1,003 279a 436
Pacific 6,058 5,842 1,934 1,707 832 713
COUNTY TYPE            
Large Metro 17,589 17,242 5,489 5,565 2,182 2,320
Small Metro 10,062 10,456 3,307 3,549 1,339 1,509
250K - 1 Mil. Pop. 6,613 7,044 2,095 2,387 890 916
< 250K Pop. 3,449 3,412 1,213 1,162 449 593
Nonmetro 4,988 5,105 1,507 1,708 645 796
Urbanized 2,265 2,514 636a 876 280 393
Less Urbanized 2,367 2,222 769 748 324 353
Completely Rural 356 369 102 84 41 50
120405
Table 1.87B (REVISED) – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Percentages, 2008 and 2009
Geographic Characteristic Lifetime
(2008)
Lifetime
(2009)
Past Year
(2008)
Past Year
(2009)
Past Month
(2008)
Past Month
(2009)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2009 detailed tables).
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
TOTAL 14.5 14.4 4.6 4.8 1.9 2.0
GEOGRAPHIC DIVISION            
Northeast 13.5 13.2 4.0 4.4 1.7 1.9
New England 15.6 14.1 5.0 4.8 2.7 1.8
Middle Atlantic 12.7 12.9 3.7 4.3 1.3a 2.0
Midwest 14.0 13.9 4.7 4.3 1.9 1.7
East North Central 15.1 14.4 5.1 4.7 2.1 1.9
West North Central 11.6 12.8 3.8 3.5 1.4 1.2
South 13.8 14.1 4.3 4.9 1.7a 2.2
South Atlantic 13.2 13.9 3.9 4.6 1.6 2.1
East South Central 14.2 14.1 5.6 4.3 2.7 2.1
West South Central 14.5 14.5 4.5a 5.7 1.5b 2.3
West 16.9 16.5 5.3 5.2 2.1 2.2
Mountain 17.3 17.5 5.1 6.3 1.8a 2.7
Pacific 16.8 16.1 5.4 4.7 2.3 2.0
COUNTY TYPE            
Large Metro 14.7 14.3 4.6 4.6 1.8 1.9
Small Metro 14.8 15.1 4.9 5.1 2.0 2.2
250K - 1 Mil. Pop. 14.7 15.5 4.6 5.2 2.0 2.0
< 250K Pop. 15.0 14.5 5.3 4.9 2.0 2.5
Nonmetro 13.5 13.7 4.1 4.6 1.7 2.1
Urbanized 14.7 15.4 4.1a 5.4 1.8 2.4
Less Urbanized 13.1 12.9 4.3 4.3 1.8 2.0
Completely Rural 9.8 9.7 2.8 2.2 1.1 1.3
100504
Table 1.88A – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Lifetime, by Age Group: Numbers in Thousands, 2008 and 2009
Drug or Method of Administration Total
(2008)
Total
(2009)
Aged 12-17
(2008)
Aged 12-17
(2009)
Aged 18-25
(2008)
Aged 18-25
(2009)
Aged 26+
(2008)
Aged 26+
(2009)
*Low precision; no estimate reported.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
1 Refers to lifetime use of a needle to inject a drug that was not prescribed, or that was taken only for the experience or feeling it caused.
2 These drug estimates are generated from data collected on a "noncore" module of the NSDUH questionnaire. Therefore, these estimates may be somewhat inconsistent with drug estimates based on data collected from the "core" modules because NSDUH data are not edited for consistency across the "core" and "noncore" modules of the interview.
3 Estimates of Stimulant Needle Use, Methamphetamine Needle Use, and the Needle Use summary variable include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
HALLUCINOGENS 35,963 37,256 973 1,012 5,836b 6,365 29,155 29,879
PCP (Angel Dust, Phencyclidine) 6,631 6,239 102 99 513 468 6,016 5,672
LSD (Acid) 23,547 23,635 268 249 2,145 2,294 21,133 21,092
Peyote 5,375 5,196 55 63 379 345 4,941 4,788
Mescaline 8,188 8,252 42 26 348 356 7,798 7,870
Psilocybin (Mushrooms) 19,792a 21,170 413 406 3,511a 3,810 15,869 16,954
"Ecstasy" (MDMA) 12,924b 14,234 531 572 3,992 4,168 8,400a 9,494
INHALANTS 22,274 22,448 2,307 2,267 3,411 3,581 16,555 16,599
Amyl Nitrite, "Poppers," Locker Room "Odorizers, or Rush" 8,117 7,407 399 370 596 565 7,123 6,472
Correction Fluid, Degreaser, or Cleaning Fluid 1,912 1,818 536 460 303 308 1,072 1,050
Gasoline or Lighter Fluid 3,674 3,743 774 773 521 521 2,378 2,449
Glue, Shoe Polish, or Toluene 3,794 3,558 863 784 469 463 2,462 2,311
Halothane, Ether, or Other Anesthetics 1,054 1,158 79 74 203 215 772 868
Lacquer Thinner or Other Paint Solvents 1,725 1,710 375 353 286 309 1,064 1,048
Lighter Gases (Butane, Propane) 960 926 246 227 165 162 549 538
Nitrous Oxide or "Whippits" 11,187a 12,401 237 258 2,189 2,260 8,761a 9,883
Spray Paints 2,105 1,998 754 713 374 381 977 904
Other Aerosol Sprays 2,213 2,381 531 501 616 629 1,066 1,252
NEEDLE USE1,2,3 4,114 3,782 59 59 307b 427 3,748 3,296
Heroin Needle Use1,2 1,911 1,499 25 27 157a 216 1,729a 1,256
Cocaine Needle Use1,2 2,366 2,119 15 16 117 152 2,234 1,951
Stimulant Needle Use1,2,3 2,013 1,920 26 26 129a 184 1,858 1,710
Methamphetamine Needle Use1,2,3 1,481 1,589 18 18 98a 147 1,366 1,424
HEROIN 3,788 3,683 68 56 457a 573 3,263 3,054
Smoke Heroin2 1,255 1,358 29 30 168 226 1,058 1,102
Sniff or Snort Heroin2 2,686 2,516 34 27 324b 442 2,328 2,047
100504
Table 1.88B – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Lifetime, by Age Group: Percentages, 2008 and 2009
Drug or Method of Administration Total
(2008)
Total
(2009)
Aged 12-17
(2008)
Aged 12-17
(2009)
Aged 18-25
(2008)
Aged 18-25
(2009)
Aged 26+
(2008)
Aged 26+
(2009)
*Low precision; no estimate reported.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
1 Refers to lifetime use of a needle to inject a drug that was not prescribed, or that was taken only for the experience or feeling it caused.
2 These drug estimates are generated from data collected on a "noncore" module of the NSDUH questionnaire. Therefore, these estimates may be somewhat inconsistent with drug estimates based on data collected from the "core" modules because NSDUH data are not edited for consistency across the "core" and "noncore" modules of the interview.
3 Estimates of Stimulant Needle Use, Methamphetamine Needle Use, and the Needle Use summary variable include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
HALLUCINOGENS 14.4 14.8 3.9 4.1 17.7a 19.0 15.2 15.4
PCP (Angel Dust, Phencyclidine) 2.7 2.5 0.4 0.4 1.6 1.4 3.1 2.9
LSD (Acid) 9.4 9.4 1.1 1.0 6.5 6.8 11.0 10.9
Peyote 2.2 2.1 0.2 0.3 1.2 1.0 2.6 2.5
Mescaline 3.3 3.3 0.2 0.1 1.1 1.1 4.1 4.1
Psilocybin (Mushrooms) 7.9 8.4 1.7 1.7 10.7 11.3 8.3 8.8
"Ecstasy" (MDMA) 5.2a 5.7 2.1 2.3 12.1 12.4 4.4a 4.9
INHALANTS 8.9 8.9 9.3 9.2 10.4 10.7 8.6 8.6
Amyl Nitrite, "Poppers," Locker Room "Odorizers, or Rush" 3.2 2.9 1.6 1.5 1.8 1.7 3.7 3.3
Correction Fluid, Degreaser, or Cleaning Fluid 0.8 0.7 2.2 1.9 0.9 0.9 0.6 0.5
Gasoline or Lighter Fluid 1.5 1.5 3.1 3.1 1.6 1.6 1.2 1.3
Glue, Shoe Polish, or Toluene 1.5 1.4 3.5 3.2 1.4 1.4 1.3 1.2
Halothane, Ether, or Other Anesthetics 0.4 0.5 0.3 0.3 0.6 0.6 0.4 0.4
Lacquer Thinner or Other Paint Solvents 0.7 0.7 1.5 1.4 0.9 0.9 0.6 0.5
Lighter Gases (Butane, Propane) 0.4 0.4 1.0 0.9 0.5 0.5 0.3 0.3
Nitrous Oxide or "Whippits" 4.5a 4.9 1.0 1.0 6.6 6.7 4.6a 5.1
Spray Paints 0.8 0.8 3.0 2.9 1.1 1.1 0.5 0.5
Other Aerosol Sprays 0.9 0.9 2.1 2.0 1.9 1.9 0.6 0.6
NEEDLE USE1,2,3 1.6 1.5 0.2 0.2 0.9b 1.3 2.0 1.7
Heroin Needle Use1,2 0.8a 0.6 0.1 0.1 0.5 0.6 0.9a 0.6
Cocaine Needle Use1,2 0.9 0.8 0.1 0.1 0.4 0.5 1.2 1.0
Stimulant Needle Use1,2,3 0.8 0.8 0.1 0.1 0.4 0.5 1.0 0.9
Methamphetamine Needle Use1,2,3 0.6 0.6 0.1 0.1 0.3a 0.4 0.7 0.7
HEROIN 1.5 1.5 0.3 0.2 1.4a 1.7 1.7 1.6
Smoke Heroin2 0.5 0.5 0.1 0.1 0.5 0.7 0.6 0.6
Sniff or Snort Heroin2 1.1 1.0 0.1 0.1 1.0b 1.3 1.2 1.1
100504
Table 1.89A – Nonmedical Use of Specific Pain Relievers in Lifetime, by Age Group: Numbers in Thousands, 2008 and 2009
Pain Reliever Total
(2008)
Total
(2009)
Aged 12-17
(2008)
Aged 12-17
(2009)
Aged 18-25
(2008)
Aged 18-25
(2009)
Aged 26+
(2008)
Aged 26+
(2009)
*Low precision; no estimate reported.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
1 Includes other-specify drug responses that are not asked about explicitly in the Pain Relievers module but fall into this category.
2 Includes Darvocet®, Darvon® or Tylenol® with Codeine, codeine, Phenaphen® with Codeine, propoxyphene, and SK-65®.
3 Includes Percocet®, Percodan® or Tylox®, and OxyContin®.
4 Includes Vicodin®, Lortab®, or Lorcet®, and hydrocodone.
5 Includes tramadol and Ultram®.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
Darvocet®, Darvon®, or Tylenol® with Codeine 19,180 18,889 1,017 1,051 3,451 3,475 14,712 14,363
Percocet®, Percodan®, or Tylox® 12,262b 13,570 411 469 2,894b 3,219 8,957 9,883
Vicodin®, Lortab®, or Lorcet® 21,224 22,065 1,167 1,104 5,922 6,088 14,134 14,873
Codeine 6,721 7,120 329 349 1,790 1,953 4,603 4,818
Demerol® 2,121 2,219 52 61 400 445 1,669 1,712
Dilaudid® 1,212 1,092 16 20 153 193 1,044 879
Fioricet® 538 430 17 16 54 82 467 332
Fiorinal® 349 342 15 8 33 25 301 309
Hydrocodone 8,363b 9,626 387 429 2,667a 2,950 5,309a 6,248
Methadone 1,811 2,026 116 115 660 688 1,034 1,223
Morphine 2,677 2,748 173 182 822b 985 1,682 1,580
OxyContin® 4,842b 5,829 341 378 1,736b 2,084 2,766a 3,368
Phenaphen® with Codeine 650 602 34 44 145 159 471 399
Propoxyphene 379 318 27 22 90 100 262 196
SK-65® 56 67 10 6 11 18 35 43
Stadol® 172 81 7 2 15 26 150 53
Talacen® 39 77 10 9 11 7 18 60
Talwin® 293 234 7 11 12 10 275 213
Talwin® NX 75 78 2 5 10 15 62 58
Tramadol 971b 1,443 41b 90 346b 567 584 786
Ultram® 1,019b 1,359 42 54 294 362 683a 943
SELECTED GROUPS OF DRUGS1                
Propoxyphene or Codeine Products2 21,128 20,985 1,173 1,201 4,069 4,135 15,886 15,649
Oxycodone Products3 13,759b 15,281 601 691 3,561a 3,893 9,597a 10,697
Hydrocodone Products4 22,838 23,543 1,295 1,238 6,323 6,512 15,219 15,794
Tramadol Products5 1,607b 2,181 74b 129 522b 762 1,012 1,289
100504
Table 1.89B – Nonmedical Use of Specific Pain Relievers in Lifetime, by Age Group: Percentages, 2008 and 2009
Pain Reliever Total
(2008)
Total
(2009)
Aged 12-17
(2008)
Aged 12-17
(2009)
Aged 18-25
(2008)
Aged 18-25
(2009)
Aged 26+
(2008)
Aged 26+
(2009)
*Low precision; no estimate reported.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
1 Includes other-specify drug responses that are not asked about explicitly in the Pain Relievers module but fall into this category.
2 Includes Darvocet®, Darvon® or Tylenol® with Codeine, codeine, Phenaphen® with Codeine, propoxyphene, and SK-65®.
3 Includes Percocet®, Percodan® or Tylox®, and OxyContin®.
4 Includes Vicodin®, Lortab®, or Lorcet®, and hydrocodone.
5 Includes tramadol and Ultram®.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
Darvocet®, Darvon®, or Tylenol® with Codeine 7.7 7.5 4.1 4.3 10.5 10.3 7.7 7.4
Percocet®, Percodan®, or Tylox® 4.9a 5.4 1.7 1.9 8.8a 9.6 4.7 5.1
Vicodin®, Lortab®, or Lorcet® 8.5 8.8 4.7 4.5 18.0 18.1 7.4 7.7
Codeine 2.7 2.8 1.3 1.4 5.4 5.8 2.4 2.5
Demerol® 0.8 0.9 0.2 0.2 1.2 1.3 0.9 0.9
Dilaudid® 0.5 0.4 0.1 0.1 0.5 0.6 0.5 0.5
Fioricet® 0.2 0.2 0.1 0.1 0.2 0.2 0.2 0.2
Fiorinal® 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.2
Hydrocodone 3.3b 3.8 1.6 1.7 8.1 8.8 2.8a 3.2
Methadone 0.7 0.8 0.5 0.5 2.0 2.0 0.5 0.6
Morphine 1.1 1.1 0.7 0.7 2.5a 2.9 0.9 0.8
OxyContin® 1.9b 2.3 1.4 1.5 5.3b 6.2 1.4a 1.7
Phenaphen® with Codeine 0.3 0.2 0.1 0.2 0.4 0.5 0.2 0.2
Propoxyphene 0.2 0.1 0.1 0.1 0.3 0.3 0.1 0.1
SK-65® 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0
Stadol® 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0
Talacen® 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Talwin® 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1
Talwin® NX 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Tramadol 0.4b 0.6 0.2b 0.4 1.1b 1.7 0.3 0.4
Ultram® 0.4b 0.5 0.2 0.2 0.9 1.1 0.4a 0.5
SELECTED GROUPS OF DRUGS1                
Propoxyphene or Codeine Products2 8.5 8.3 4.7 4.9 12.4 12.3 8.3 8.1
Oxycodone Products3 5.5b 6.1 2.4a 2.8 10.8a 11.6 5.0a 5.5
Hydrocodone Products4 9.1 9.3 5.2 5.0 19.2 19.4 7.9 8.2
Tramadol Products5 0.6b 0.9 0.3b 0.5 1.6b 2.3 0.5 0.7
100504
Table 1.90A – Nonmedical Use of Specific Tranquilizers in Lifetime, by Age Group: Numbers in Thousands, 2008 and 2009
Tranquilizer Total
(2008)
Total
(2009)
Aged 12-17
(2008)
Aged 12-17
(2009)
Aged 18-25
(2008)
Aged 18-25
(2009)
Aged 26+
(2008)
Aged 26+
(2009)
*Low precision; no estimate reported.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
1 Includes other-specify drug responses that are not asked about explicitly in the Tranquilizers module but fall into this category.
2 Includes Klonopin® or clonazepam, Xanax®, alprazolam, Ativan® or lorazepam, Valium® or diazepam, Librium®, Limbitrol®, Rohypnol®, Serax®, and Tranxene®.
3 Includes Equanil®, meprobamate, and Miltown®.
4 Includes Flexeril® and Soma®.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
Klonopin® or Clonazepam 3,945a 4,725 137 162 1,187b 1,400 2,620 3,163
Xanax®, Alprazolam, Ativan®, or Lorazepam 12,710 12,846 507 487 2,977b 3,346 9,225 9,014
Valium® or Diazepam 14,023 13,338 250 210 2,103 1,992 11,670 11,136
Atarax® 283 307 15 20 45 39 223 248
BuSpar® 679 489 26 26 144 148 508 314
Equanil® 38 73 9 5 14 12 15 56
Flexeril® 2,461 2,399 42 46 538 539 1,881 1,814
Librium® 818 874 20 14 42 47 755 812
Limbitrol® 51 87 10 14 10a 34 30 40
Meprobamate 77 106 11 12 17 21 49 73
Miltown® 117 76 6 4 7 5 104 66
Rohypnol® 297 295 25 22 82 66 190 207
Serax® 113 74 8 11 22 21 83 42
Soma® 2,833 2,949 99 104 933 928 1,800 1,917
Tranxene® 195 157 6 16 24 20 165 121
Vistaril® 298 200 14 14 42 46 242 140
SELECTED GROUPS OF DRUGS1                
Benzodiazepines2 20,147 20,449 633 625 3,806a 4,086 15,709 15,739
Meprobamate Products3 183 228 21 19 32 27 130 182
Muscle Relaxants4 4,414 4,453 136 140 1,222 1,205 3,055 3,108
100504
Table 1.90B – Nonmedical Use of Specific Tranquilizers in Lifetime, by Age Group: Percentages, 2008 and 2009
Tranquilizer Total
(2008)
Total
(2009)
Aged 12-17
(2008)
Aged 12-17
(2009)
Aged 18-25
(2008)
Aged 18-25
(2009)
Aged 26+
(2008)
Aged 26+
(2009)
*Low precision; no estimate reported.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
1 Includes other-specify drug responses that are not asked about explicitly in the Tranquilizers module but fall into this category.
2 Includes Klonopin® or clonazepam, Xanax®, alprazolam, Ativan® or lorazepam, Valium® or diazepam, Librium®, Limbitrol®, Rohypnol®, Serax®, and Tranxene®.
3 Includes Equanil®, meprobamate, and Miltown®.
4 Includes Flexeril® and Soma®.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
Klonopin® or Clonazepam 1.6a 1.9 0.6 0.7 3.6a 4.2 1.4 1.6
Xanax®, Alprazolam, Ativan®, or Lorazepam 5.1 5.1 2.0 2.0 9.0a 10.0 4.8 4.7
Valium® or Diazepam 5.6 5.3 1.0 0.9 6.4 5.9 6.1 5.8
Atarax® 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
BuSpar® 0.3 0.2 0.1 0.1 0.4 0.4 0.3 0.2
Equanil® 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Flexeril® 1.0 1.0 0.2 0.2 1.6 1.6 1.0 0.9
Librium® 0.3 0.3 0.1 0.1 0.1 0.1 0.4 0.4
Limbitrol® 0.0 0.0 0.0 0.1 0.0a 0.1 0.0 0.0
Meprobamate 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0
Miltown® 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0
Rohypnol® 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.1
Serax® 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0
Soma® 1.1 1.2 0.4 0.4 2.8 2.8 0.9 1.0
Tranxene® 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1
Vistaril® 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
SELECTED GROUPS OF DRUGS1                
Benzodiazepines2 8.1 8.1 2.5 2.5 11.6 12.2 8.2 8.1
Meprobamate Products3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
Muscle Relaxants4 1.8 1.8 0.5 0.6 3.7 3.6 1.6 1.6
100504
Table 1.91A – Nonmedical Use of Specific Stimulants in Lifetime, by Age Group: Numbers in Thousands, 2008 and 2009
Stimulant Total
(2008)
Total
(2009)
Aged 12-17
(2008)
Aged 12-17
(2009)
Aged 18-25
(2008)
Aged 18-25
(2009)
Aged 26+
(2008)
Aged 26+
(2009)
*Low precision; no estimate reported.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
1 Also known as crank, crystal, ice, or speed. Estimates of Use of Methamphetamine, Desoxyn®, or Methedrine include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
2 Respondents were asked about their use of prescription diet pills and were given the following as examples: amphetamines, Benzedrine®, Biphetamine®, Fastin®, or phentermine. However, respondents were not given an exhaustive list of examples of prescription diet pills.
3 Includes other-specify drug responses that are not asked about explicitly in the Stimulants module but fall into this category.
4 Includes prescription diet pills, Dexedrine®, dextroamphetamine, and Ionamin®.
5 Includes Mazanor® and Sanorex®.
6 Includes Ritalin®, other products containing methylphenidate, and products containing dexmethylphenidate.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
Methamphetamine, Desoxyn®, or Methedrine1 12,598 12,837 195 185 1,544 1,511 10,859 11,141
Prescription Diet Pills2 7,533 7,861 180 158 694 693 6,659 7,010
Ritalin® or Methylphenidate 4,808 5,363 325 269 1,559a 1,754 2,923 3,340
Cylert® 168 181 13 13 30 33 125 135
Dexedrine® 2,262 2,357 16 21 179 164 2,067 2,172
Dextroamphetamine 558 668 21 28 129a 183 408 457
Didrex® 127 203 16 9 8 22 103 171
Eskatrol® 150 150 11 9 8 13 132 128
Ionamin® 181 362 5 15 6 8 170 339
Mazanor® 49 21 11 5 2 6 35 10
Obedrin-LA® * * 8 6 4 4 * *
Plegine® 35 20 10 6 11 8 14 *
Preludin® 529 392 10 9 12 16 507 367
Sanorex® 99 67 13 9 24 19 62 38
Tenuate® 111 118 9 6 3 11 99 100
SELECTED GROUPS OF DRUGS3                
Amphetamine, Dextroamphetamine, and Phentermine Products4 9,283 9,794 255 239 1,345 1,424 7,683 8,131
Mazindol Products5 130 84 20 13 25 22 85 48
Methylphenidate or Dexmethylphenidate Products6 4,823 5,376 325 270 1,569a 1,766 2,929 3,340
100504
Table 1.91B – Nonmedical Use of Specific Stimulants in Lifetime, by Age Group: Percentages, 2008 and 2009
Stimulant Total
(2008)
Total
(2009)
Aged 12-17
(2008)
Aged 12-17
(2009)
Aged 18-25
(2008)
Aged 18-25
(2009)
Aged 26+
(2008)
Aged 26+
(2009)
*Low precision; no estimate reported.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
1 Also known as crank, crystal, ice, or speed. Estimates of Use of Methamphetamine, Desoxyn®, or Methedrine include data from methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
2 Respondents were asked about their use of prescription diet pills and were given the following as examples: amphetamines, Benzedrine®, Biphetamine®, Fastin®, or phentermine. However, respondents were not given an exhaustive list of examples of prescription diet pills.
3 Includes other-specify drug responses that are not asked about explicitly in the Stimulants module but fall into this category.
4 Includes prescription diet pills, Dexedrine®, dextroamphetamine, and Ionamin®.
5 Includes Mazanor® and Sanorex®.
6 Includes Ritalin®, other products containing methylphenidate, and products containing dexmethylphenidate.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
Methamphetamine, Desoxyn®, or Methedrine1 5.0 5.1 0.8 0.8 4.7 4.5 5.7 5.8
Prescription Diet Pills2 3.0 3.1 0.7 0.6 2.1 2.1 3.5 3.6
Ritalin® or Methylphenidate 1.9 2.1 1.3 1.1 4.7 5.2 1.5 1.7
Cylert® 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
Dexedrine® 0.9 0.9 0.1 0.1 0.5 0.5 1.1 1.1
Dextroamphetamine 0.2 0.3 0.1 0.1 0.4 0.5 0.2 0.2
Didrex® 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1
Eskatrol® 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1
Ionamin® 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.2
Mazanor® 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Obedrin-LA® * * 0.0 0.0 0.0 0.0 * *
Plegine® 0.0 0.0 0.0 0.0 0.0 0.0 0.0 *
Preludin® 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.2
Sanorex® 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0
Tenuate® 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1
SELECTED GROUPS OF DRUGS3                
Amphetamine, Dextroamphetamine, and Phentermine Products4 3.7 3.9 1.0 1.0 4.1 4.2 4.0 4.2
Mazindol Products5 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0
Methylphenidate or Dexmethylphenidate Products6 1.9 2.1 1.3 1.1 4.8 5.3 1.5 1.7
100504
Table 1.92A – Nonmedical Use of Specific Sedatives in Lifetime, by Age Group: Numbers in Thousands, 2008 and 2009
Sedative Total
(2008)
Total
(2009)
Aged 12-17
(2008)
Aged 12-17
(2009)
Aged 18-25
(2008)
Aged 18-25
(2009)
Aged 26+
(2008)
Aged 26+
(2009)
*Low precision; no estimate reported.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
1 Respondents were asked about their use of barbiturates and were given the following as examples: Nembutal®, pentobarbital, Seconal®, secobarbital, or butalbital. However, respondents were not given an exhaustive list of examples of barbiturates.
2 Includes other-specify drug responses that are not asked about explicitly in the Sedatives module but fall into this category.
3
Includes Restoril®, temazepam, Dalmane®, or Halcion®.
4 Includes barbiturates, Amytal®, Butisol®, phenobarbital, and Tuinal®.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
Methaqualone, Sopor®, or Quaalude® 5,794 5,728 30 25 149 154 5,615 5,549
Barbiturates1 2,854 2,449 29 27 72 85 2,754 2,337
Restoril® or Temazepam 914 1,187 43 46 114 147 757 994
Amytal® 169 210 10 9 25 24 134 177
Butisol® 95 84 15 6 3 7 78 71
Chloral Hydrate 193 153 4 2 5 19 184 132
Dalmane® 264 281 26 16 9 18 230 247
Halcion® 506 526 16 15 19 25 471 486
Phenobarbital 1,214 982 18 16 70 62 1,126 904
Placidyl® 533 493 6 2 8 5 518 486
Tuinal® 1,019 729 5 10 5 6 1,009 713
SELECTED GROUPS OF DRUGS2                
Temazepam, Flurazepam, or Triazolam3 1,485 1,667 72 70 134 164 1,280 1,433
Any Barbiturates4 3,478 3,036 54 54 136 149 3,288 2,833
100504
Table 1.92B – Nonmedical Use of Specific Sedatives in Lifetime, by Age Group: Percentages, 2008 and 2009
Sedative Total
(2008)
Total
(2009)
Aged 12-17
(2008)
Aged 12-17
(2009)
Aged 18-25
(2008)
Aged 18-25
(2009)
Aged 26+
(2008)
Aged 26+
(2009)
*Low precision; no estimate reported.
a Difference between estimate and 2009 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2009 estimate is statistically significant at the 0.01 level.
1 Respondents were asked about their use of barbiturates and were given the following as examples: Nembutal®, pentobarbital, Seconal®, secobarbital, or butalbital. However, respondents were not given an exhaustive list of examples of barbiturates.
2 Includes other-specify drug responses that are not asked about explicitly in the Sedatives module but fall into this category.
3
Includes Restoril®, temazepam, Dalmane®, or Halcion®.
4 Includes barbiturates, Amytal®, Butisol®, phenobarbital, and Tuinal®.
Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2008 and 2009.
Methaqualone, Sopor®, or Quaalude® 2.3 2.3 0.1 0.1 0.5 0.5 2.9 2.9
Barbiturates1 1.1 1.0 0.1 0.1 0.2 0.3 1.4 1.2
Restoril® or Temazepam 0.4 0.5 0.2 0.2 0.3 0.4 0.4 0.5
Amytal® 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1
Butisol® 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0
Chloral Hydrate 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1
Dalmane® 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1
Halcion® 0.2 0.2 0.1 0.1 0.1 0.1 0.2 0.3
Phenobarbital 0.5 0.4 0.1 0.1 0.2 0.2 0.6 0.5
Placidyl® 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.3
Tuinal® 0.4 0.3 0.0 0.0 0.0 0.0 0.5 0.4
SELECTED GROUPS OF DRUGS2                
Temazepam, Flurazepam, or Triazolam3 0.6 0.7 0.3 0.3 0.4 0.5 0.7 0.7
Any Barbiturates4 1.4 1.2 0.2 0.2 0.4 0.4 1.7 1.5

Go to Top of PageGo to the Table of Contents

This is the page footer.

This page was last updated on .